Section 13

EurekaMag PDF full texts Chapter 12,714


Martins, E.J.; Ferreira, A.C.F.; Skorupa, A.L.; Afeche, S.C.; Cipolla Neto, J.; Rosa, L.F.B.P.C.sta 2004: Tryptophan consumption and indoleamines production by peritoneal cavity macrophages. Journal of Leukocyte Biology 75(6): 1116-1121
Durrant, J.Devin.; Caywood, D.; Busath, D.D. 2006: Tryptophan contributions to the empirical free-energy profile in gramicidin A/M heterodimer channels. Biophysical Journal 91(9): 3230-3241
Vrensen, G.F.J.M.; van Marle, J.; Jonges, R.; Voorhout, W.; Breipohl, W.; Wegener, A.R. 2004: Tryptophan deficiency arrests chromatin breakdown in secondary lens fibers of rats. Experimental Eye Research 78(3): 661-672
Schroecksnadel, K.; Winkler, C.; Fuith, L.C.; Fuchs, D. 2005: Tryptophan degradation in patients with gynecological cancer correlates with immune activation. Cancer Letters 223(2): 323-329
Booij, L.; Swenne, C.A.; Brosschot, J.F.; Haffmans, P.M.Judith.; Thayer, J.F.; Van der Does, A.J.Willem. 2006: Tryptophan depletion affects heart rate variability and impulsivity in remitted depressed patients with a history of suicidal ideation. Biological Psychiatry 60(5): 507-514
Selvaraj, S.; Wylezinska, M.; Evans, J.; Jezzard, P.; Matthews, P.M.; Cowen, P.J. 2006: Tryptophan depletion does not lower brain GABA levels in healthy volunteers. Psychopharmacology 187(1): 131-132
Tõru, I.; Shlik, J.; Maron, E.; Vasar, V.; Nutt, D.J. 2006: Tryptophan depletion does not modify response to CCK-4 challenge in patients with panic disorder after treatment with citalopram. Psychopharmacology 186(1): 107-112
Drummond, P.D. 2006: Tryptophan depletion increases nausea, headache and photophobia in migraine sufferers. Cephalalgia: An International Journal of Headache 26(10): 1225-1233
Rubia, K.; Lee, F.; Cleare, A.J.; Tunstall, N.; Fu, C.H.Y.; Brammer, M.; McGuire, P. 2005: Tryptophan depletion reduces right inferior prefrontal activation during response inhibition in fast, event-related fMRI. Psychopharmacology 179(4): 791-803
Argyropoulos, S.V.; Hood, S.D.; Adrover, M.; Bell, C.J.; Rich, A.S.; Nash, J.R.; Rich, N.C.; Witchel, H.J.; Nutt, D.J. 2004: Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder. Biological Psychiatry 56(7): 503-509
Sultan, N.A.M.; Rao, R.N.; Nadimpalli, S.K.; Swamy, M.J. 2006: Tryptophan environment, secondary structure and thermal unfolding of the galactose-specific seed lectin from Dolichos lablab: fluorescence and circular dichroism spectroscopic studies. Biochimica et Biophysica Acta 1760(7): 1001-1008
Losi, A.; Ternelli, E.; Gärtner, W. 2004: Tryptophan fluorescence in the Bacillus subtilis phototropin-related protein YtvA as a marker of interdomain interaction. Photochemistry and Photobiology 80: 150-153
De Luca, V.; Likhodi, O.; Van Tol, H.H.M.; Kennedy, J.L.; Wong, A.H.C. 2005: Tryptophan hydroxylase 2 gene expression and promoter polymorphisms in bipolar disorder and schizophrenia. Psychopharmacology 183(3): 378-382
Slominski, A.; Pisarchik, A.; Johansson, O.; Jing, C.; Semak, I.; Slugocki, G.; Wortsman, J. 2003: Tryptophan hydroxylase expression in human skin cells. Biochimica et Biophysica Acta 1639(2): 80-86
Koller, G.; Engel, R.R.; Preuss, U.W.; Karakesisoglou, A.; Zill, P.; Bondy, B.; Soyka, M. 2005: Tryptophan hydroxylase gene 1 polymorphisms are not associated with suicide attempts in alcohol-dependent individuals. Addiction Biology 10(3): 269-273
Chung, I.-W.; Kim, H.; Sribney, W.; Hong, J.-B.; Lee, C.-H.; Lee, K.-Y.; Nan, H.-M.; Kim, Y.-S.; Manowitz, P. 2005: Tryptophan hydroxylase polymorphism is associated with age of onset of alcoholism related behaviors. Alcohol 36(1): 1-3
Forrest, C.M.; Mackay, G.M.; Stoy, N.; Egerton, M.; Christofides, J.; Stone, T.W.; Darlington, L.G. 2004: Tryptophan loading induces oxidative stress. Free Radical Research 38(11): 1167-1171
Stoy, N.; Mackay, G.M.; Forrest, C.M.; Christofides, J.; Egerton, M.; Stone, T.W.; Darlington, L.G. 2005: Tryptophan metabolism and oxidative stress in patients with Huntington's disease. Journal of Neurochemistry 93(3): 611-623
Mackay, G.M.; Forrest, C.M.; Stoy, N.; Christofides, J.; Egerton, M.; Stone, T.W.; Darlington, L.G. 2006: Tryptophan metabolism and oxidative stress in patients with chronic brain injury. European Journal of Neurology 13(1): 30-42
Strohalm, M.; Kodícek, M.; Pechar, M. 2003: Tryptophan modification by 2-hydroxy-5-nitrobenzyl bromide studied by MALDI-TOF mass spectrometry. Biochemical and Biophysical Research Communications 312(3): 811-816
Svistunenko, D.A.; Wilson, M.T.; Cooper, C.E. 2004: Tryptophan or tyrosine? on the nature of the amino acid radical formed following hydrogen peroxide treatment of cytochrome c oxidase. Biochimica et Biophysica Acta 1655(1-3): 372-380
Broos, J.; Gabellieri, E.; van Boxel, G.I.; Jackson, J.Baz.; Strambini, G.B. 2003: Tryptophan phosphorescence spectroscopy reveals that a domain in the NAD(H)-binding component (dI) of transhydrogenase from Rhodospirillum rubrum has an extremely rigid and conformationally homogeneous protein core. Journal of Biological Chemistry 278(48): 47578-47584
Wood, H.; Roshick, C.; McClarty, G. 2004: Tryptophan recycling is responsible for the interferon-gamma resistance of Chlamydia psittaci GPIC in indoleamine dioxygenase-expressing host cells. Molecular Microbiology 52(3): 903-916
Cornelio, A.R.; Rodrigues, V.ês.; de Souza Wyse, A.T.; Dutra-Filho, C.S.; Wajner, M.; Wannmacher, C.M.D. 2004: Tryptophan reduces creatine kinase activity in the brain cortex of rats. International Journal of Developmental Neuroscience: the Official Journal of the International Society for Developmental Neuroscience 22(2): 95-101
Carra', G.; Calo', G.; Spagnolo, B.; Guerrini, R.; Arduin, M.; Marzola, E.; Trapella, C.; Regoli, D.; Salvadori, S. 2005: Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2. Journal of Peptide Research: Official Journal of the American Peptide Society 66(1): 39-47
Draheim, R.R.; Bormans, A.F.; Lai, R-zhi.; Manson, M.D. 2005: Tryptophan residues flanking the second transmembrane helix (TM2) set the signaling state of the Tar chemoreceptor. Biochemistry 44(4): 1268-1277
Katsuki, M.; Chuang, V.Tuan.Giam.; Nishi, K.; Suenaga, A.; Otagiri, M. 2004: Tryptophan residues play an important role in the extraordinarily high affinity binding interaction of UCN-01 to human alpha-1-acid glycoprotein. Pharmaceutical Research 21(9): 1648-1655
Moors, S.L.C.; Hellings, M.; De Maeyer, M.; Engelborghs, Y.; Ceulemans, A. 2006: Tryptophan rotamers as evidenced by X-ray, fluorescence lifetimes, and molecular dynamics modeling. Biophysical Journal 91(3): 816-823
Santiago, J.; Guzmán, G.R.; Torruellas, K.; Rojas, L.V.; Lasalde-Dominicci, J.é A. 2004: Tryptophan scanning mutagenesis in the TM3 domain of the Torpedo californica acetylcholine receptor beta subunit reveals an alpha-helical structure. Biochemistry 43(31): 10064-10070
Guzmán, G.R.; Santiago, J.; Ricardo, A.; Martí-Arbona, R.; Rojas, L.V.; Lasalde-Dominicci, J.é A. 2003: Tryptophan scanning mutagenesis in the alphaM3 transmembrane domain of the Torpedo californica acetylcholine receptor: functional and structural implications. Biochemistry 42(42): 12243-12250
Subbiah, R.N.; Kondo, M.; Campbell, T.J.; Vandenberg, J.I. 2005: Tryptophan scanning mutagenesis of the HERG K+ channel: the S4 domain is loosely packed and likely to be lipid exposed. Journal of Physiology 569(Pt 2): 367-379
Ortiz-Acevedo, A.; Melendez, M.; Asseo, A.M.; Biaggi, N.; Rojas, L.V.; Lasalde-Dominicci, Jé.A. 2004: Tryptophan scanning mutagenesis of the gammaM4 transmembrane domain of the acetylcholine receptor from Torpedo californica. Journal of Biological Chemistry 279(40): 42250-42257
Wang, S-Ya.; Russell, C.; Wang, G.Kuo. 2005: Tryptophan substitution of a putative D4S6 gating hinge alters slow inactivation in cardiac sodium channels. Biophysical Journal 88(6): 3991-3999
Navedo, M.; Nieves, M.; Rojas, L.; Lasalde-Dominicci, J.A. 2004: Tryptophan substitutions reveal the role of nicotinic acetylcholine receptor alpha-TM3 domain in channel gating: differences between Torpedo and muscle-type AChR. Biochemistry 43(1): 78-84
Ridder, A.; Skupjen, P.; Unterreitmeier, S.; Langosch, D. 2005: Tryptophan supports interaction of transmembrane helices. Journal of Molecular Biology 354(4): 894-902
Chan, D.I.; Prenner, E.J.; Vogel, H.J. 2006: Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action. Biochimica et Biophysica Acta 1758(9): 1184-1202
Delaney, J.; Hodson, M.P.; Thakkar, H.; Connor, S.C.; Sweatman, B.C.; Kenny, S.P.; McGill, P.J.; Holder, J.C.; Hutton, K.A.; Haselden, J.N.; Waterfield, C.J. 2005: Tryptophan-NAD+ pathway metabolites as putative biomarkers and predictors of peroxisome proliferation. Archives of Toxicology 79(4): 208-223
Pogni, R.; Baratto, M.Camilla.; Giansanti, S.; Teutloff, C.; Verdin, J.; Valderrama, B.; Lendzian, F.; Lubitz, W.; Vazquez-Duhalt, R.; Basosi, R. 2005: Tryptophan-based radical in the catalytic mechanism of versatile peroxidase from Bjerkandera adusta. Biochemistry 44(11): 4267-4274
Mahalakshmi, R.; Sengupta, A.; Raghothama, S.; Shamala, N.; Balaram, P. 2005: Tryptophan-containing peptide helices: interactions involving the indole side chain. Journal of Peptide Research: Official Journal of the American Peptide Society 66(5): 277-296
Carta, M.; Fadda, F.; Stancampiano, R. 2006: Tryptophan-deficient diet increases the neurochemical and behavioral response to amphetamine. Brain Research 1094(1): 86-91
Egashira, Y.; Nagaki, S.; Sanada, H. 2006: Tryptophan-niacin metabolism in rat with puromycin aminonucleoside-induced nephrosis. International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift für Vitamin- und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition 76(1): 28-33
Schibli, D.J.; Epand, R.F.; Vogel, H.J.; Epand, R.M. 2002: Tryptophan-rich antimicrobial peptides: comparative properties and membrane interactions. Biochemistry and Cell Biology 80(5): 667-677
Kulikova, V.V.; Zakomirdina, L.N.; Dementieva, I.S.; Phillips, R.S.; Gollnick, P.D.; Demidkina, T.V.; Faleev, N.G. 2006: Tryptophanase from Proteus vulgaris: the conformational rearrangement in the active site, induced by the mutation of Tyrosine 72 to phenylalanine, and its mechanistic consequences. Biochimica et Biophysica Acta 1764(4): 750-757
Oltenfreiter, R.; Staelens, L.; Labied, S.; Kersemans, V.; Frankenne, F.; Noël, A.; Van de Wiele, C.; Slegers, G. 2006: Tryptophane-based biphenylsulfonamide matrix metalloproteinase inhibitors as tumor imaging agents. Cancer BioTherapy and Radiopharmaceuticals 20(6): 639-647
Sirangelo, I.; Iannuzzi, C.; Malmo, C.; Irace, G. 2003: Tryptophanyl substitutions in apomyoglobin affect conformation and dynamic properties of AGH subdomain. Biopolymers 70(4): 649-654
Zee, R.Y.L.; Hegener, H.H.; Chasman, D.I.; Ridker, P.M. 2005: Tryptophanyl-tRNA synthetase gene polymorphisms and risk of incident myocardial infarction. Atherosclerosis 181(1): 137-141
Shapir, N.; Pedersen, C.; Gil, O.; Strong, L.; Seffernick, J.; Sadowsky, M.J.; Wackett, L.P. 2006: TrzN from Arthrobacter aurescens TC1 Is a zinc amidohydrolase. Journal of Bacteriology 188(16): 5859-5864
Wilson, C.; Bonnet, C.; Guy, C.; Idziaszczyk, S.; Colley, J.; Humphreys, V.; Maynard, J.; Sampson, J.R.; Cheadle, J.P. 2006: Tsc1 haploinsufficiency without mammalian target of rapamycin activation is sufficient for renal cyst formation in Tsc1+/- mice. Cancer Research 66(16): 7934-7938
Kolb, T.M.; Duan, L.; Davis, M.A. 2005: Tsc2 expression increases the susceptibility of renal tumor cells to apoptosis. Toxicological Sciences: An Official Journal of the Society of Toxicology 88(2): 331-339
Dong, J.; Pan, D. 2004: Tsc2 is not a critical target of Akt during normal Drosophila development. Genes and Development 18(20): 2479-2484
Stevens, M.; Lammertyn, J.; Verbruggen, F.; Vandierendonck, Aé. 2006: Tscope: A C library for programming cognitive experiments on the MS windows platform. Behavior Research Methods 38(2): 280-286
Caljon, G.; Van Den Abbeele, J.; Sternberg, J.M.; Coosemans, M.; De Baetselier, P.; Magez, S. 2006: Tsetse fly saliva biases the immune response to Th2 and induces anti-vector antibodies that are a useful tool for exposure assessment. International Journal for Parasitology 36(9): 1025-1035
Sado, T.; Hoki, Y.; Sasaki, H. 2005: Tsix silences Xist through modification of chromatin structure. Developmental Cell 9(1): 159-165
Shibata, S.; Lee, J.T. 2004: Tsix transcription- versus RNA-based mechanisms in Xist repression and epigenetic choice. Current Biology: Cb 14(19): 1747-1754
Ohhata, T.; Hoki, Y.; Sasaki, H.; Sado, T. 2006: Tsix-deficient X chromosome does not undergo inactivation in the embryonic lineage in males: implications for Tsix-independent silencing of Xist. Cytogenetic and Genome Research 113(1-4): 345-349
Navarro, P.; Page, D.R.; Avner, P.; Rougeulle, C. 2006: Tsix-mediated epigenetic switch of a CTCF-flanked region of the Xist promoter determines the Xist transcription program. Genes and Development 20(20): 2787-2792
Surace, E.I.; Strickland, A.; Hess, R.A.; Gutmann, D.H.; Naughton, C.K. 2006: Tslc1 (nectin-like molecule-2) is essential for spermatozoa motility and male fertility. Journal of Andrology 27(6): 816-825
Kappé, G.; Aquilina, J.Andrew.; Wunderink, L.; Kamps, B.; Robinson, C.V.; Garate, T.; Boelens, W.C.; de Jong, W.W. 2004: Tsp36, a tapeworm small heat-shock protein with a duplicated alpha-crystallin domain, forms dimers and tetramers with good chaperone-like activity. Proteins 57(1): 109-117
Kim, Y.-S.; Nakanishi, G.; Oudes, A.J.; Kim, K.H.; Wang, H.; Kilpatrick, D.L.; Jetten, A.M. 2004: Tsp57: a novel gene induced during a specific stage of spermatogenesis. Biology of Reproduction 70(1): 106-113
Karwacki, V.; Kovac, J.; Mauceri, G.; Backhaus, A.; Föhse, L.; Schmidtke, J.ör.; Schubert, S. 2006: Tspy is nonfunctional in the Mongolian gerbil but functional in the Syrian hamster. Genomics 88(1): 65-73
Gibson, K.J.C.; Gilleron, M.; Constant, P.; Brando, T.ér.ès.; Puzo, G.; Besra, G.S.; Nigou, J.ér.ôm. 2004: Tsukamurella paurometabola lipoglycan, a new lipoarabinomannan variant with pro-inflammatory activity. Journal of Biological Chemistry 279(22): 22973-22982
Nam, S.-W.; Chun, J.; Kim, S.; Kim, W.; Zakrzewska-Czerwinska, J.; Goodfellow, M. 2003: Tsukamurella spumae sp. nov., a novel actinomycete associated with foaming in activated sludge plants. Systematic and Applied Microbiology 26(3): 367-375
Kuriyama, S.; Lupo, G.; Ohta, K.; Ohnuma, S.-I.; Harris, W.A.; Tanaka, H. 2006: Tsukushi controls ectodermal patterning and neural crest specification in Xenopus by direct regulation of BMP4 and X-delta-1 activity. Development 133(1): 75-88
Ohta, K.; Kuriyama, S.; Okafuji, T.; Gejima, R.; Ohnuma, S.-i.; Tanaka, H. 2006: Tsukushi cooperates with VG1 to induce primitive streak and Hensen's node formation in the chick embryo. Development 133(19): 3777-3786
Ohta, K.; Lupo, G.; Kuriyama, S.; Keynes, R.; Holt, C.E.; Harris, W.A.; Tanaka, H.; Ohnuma, S.-I. 2004: Tsukushi functions as an organizer inducer by inhibition of BMP activity in cooperation with chordin. Developmental Cell 7(3): 347-358
Wilder-Smith, A. 2005: Tsunami in South Asia: what is the risk of post-disaster infectious disease outbreaks?. Annals of the Academy of Medicine Singapore 34(10): 625-631
Solovieva, O.N.; Dotsenko, S.F.; Kuzin, I.P.; Levin, B.V. 2004: Tsunamis in the Black Sea: Historical events, seismic sources and regularities of propagation. Okeanologiya 44(5): 679-685
Seilmaier, M.; Guggemos, W.; Boehme, C.C.; Loescher, T. 2004: Tsutsugamushi-Fieber mach Sudostasienreise. DMW Deutsche Medizinische Wochenschrift 129(42): 2233-2235
Guazzaroni, Mía-Eugenia.; Terán, W.; Zhang, X.; Gallegos, Mía-Trinidad.; Ramos, J.L. 2004: TtgV bound to a complex operator site represses transcription of the promoter for the multidrug and solvent extrusion TtgGHI pump. Journal of Bacteriology 186(10): 2921-2927
Moller, P.-Rask; Schwarzhans, W.; Nielsen, J., G. 2004: Tuamotuichthys bispinosus, a new genus and species from off Tuamotu Islands, South Pacific Ocean (Ophiidiformes, Bythitidae). Ichthyological Research 51(2): 146-152
Remigereau, M.-S.; Robin, O.; Siljak-Yakovlev, S.; Sarr, A.; Robert, T.; Langin, T. 2006: Tuareg, a novel miniature-inverted repeat family of pearl millet (Pennisetum glaucum) related to the PIF superfamily of maize. Genetica 128(1-3): 205-216
Reilly, S.M.; McElroy, E.J.; Andrew Odum, R.; Hornyak, V.A. 2006: Tuataras and salamanders show that walking and running mechanics are ancient features of tetrapod locomotion. Proceedings. Biological Sciences 273(1593): 1563-1568
Kovacs, E.M.; Makar, R.S.; Gertler, F.B. 2006: Tuba stimulates intracellular N-WASP-dependent actin assembly. Journal of Cell Science 119(Part 13): 2715-2726
Kiran, G.; Kiran, H.; Ertopcu, K.; Kilinc, M.; Ekerbicer, H.C.; Vardar, M.A. 2005: Tuba uterina leukemia inhibitory factor concentration does not increase in tubal pregnancy: a preliminary study. Fertility and Sterility 83(2): 484-486
Salazar, M.A.; Kwiatkowski, A.V.; Pellegrini, L.; Cestra, G.; Butler, M.H.; Rossman, K.L.; Serna, D.M.; Sondek, J.; Gertler, F.B.; De Camilli, P. 2003: Tuba, a novel protein containing bin/amphiphysin/Rvs and Dbl homology domains, links dynamin to regulation of the actin cytoskeleton. Journal of Biological Chemistry 278(49): 49031-49043
Sinawat, S.; Pattamadilok, J.; Seejorn, K. 2005: Tubal abnormalities in Thai infertile females. Journal of the Medical Association of Thailand 88(6): 723-727
Bahrami, S.; Alatassi, H.; Slone, S.P.; O'Connor, D.M. 2006: Tubal gestation and schistosomiasis: a case report. Journal of Reproductive Medicine 51(7): 595-598
Nelson, D.B.; Sammel, M.D.; Freeman, E.W.; Gracia, C.R.; Liu, L.; Langan, E. 2005: Tubal ligation does not affect hormonal changes during the early menopausal transition. Contraception 71(2): 104-110
García-Ulloa, A.C.; Arrieta, O. 2005: Tubal occlusion causing infertility due to an excessive inflammatory response in patients with predisposition for keloid formation. Medical Hypotheses 65(5): 908-914
Ho, H-Yi.; Lee, R.Kuo-Kuang.; Su, J-Tsung. 2003: Tubal pregnancy following tubal embryo transfer into the contralateral fallopian tube. Journal of Assisted Reproduction and Genetics 20(10): 439-442
Whiteman, M.K.; Miller, K.P.; Tomic, D.; Langenberg, P.; Flaws, J.A. 2004: Tubal sterilization and hot flashes. Fertility and Sterility 82(2): 502-504
Kjaer, S.K.; Mellemkjaer, L.; Brinton, L.A.; Johansen, C.; Gridley, G.; Olsen, J.ør.H. 2004: Tubal sterilization and risk of ovarian, endometrial and cervical cancer. a Danish population-based follow-up study of more than 65 000 sterilized women. International Journal of Epidemiology 33(3): 596-602
Eliassen, A.H.; Colditz, G.A.; Rosner, B.; Hankinson, S.E. 2006: Tubal sterilization in relation to breast cancer risk. International Journal of Cancer 118(8): 2026-2030
McLemore, R.; Kim, E.-J.; Brandon, T.A.; Aerni, G.; Roy, K.H.; Vernon, B.L. 2005: Tubal sterilization with a waterborne polyethylene glycol in situ cross-linking material: a minimally invasive approach. Fertility and Sterility 83(Suppl 1): 1284-1292
Xi, Q.; Pauer, G.J.T.; Marmorstein, A.D.; Crabb, J.W.; Hagstrom, S.A. 2005: Tubby-like protein 1 (TULP1) interacts with F-actin in photoreceptor cells. Investigative Ophthalmology and Visual Science 46(12): 4754-4761
Harper, E., M.; Morton, B. 2004: Tube construction in the watering pot shell Brechites vaginiferus (Bivalvia; Anomalodesmata; Clavagelloidea). Acta Zoologica 85(3): 149-161
Mason, S.J.; Harris, G.; Blissett, J. 2005: Tube feeding in infancy: implications for the development of normal eating and drinking skills. Dysphagia 20(1): 46-61
Nelson, W.James. 2003: Tube morphogenesis: closure, but many openings remain. Trends in Cell Biology 13(12): 615-621
Kristensen, M.S. 2005: Tube tip in pharynx (TTIP) ventilation: simple establishment of ventilation in case of failed mask ventilation. Acta Anaesthesiologica Scandinavica 49(2): 252-256
Lemieux, R.; Czetwertynski, S. 2006: Tube traps and rubber padded snares for capturing American black bears. Ursus 17(1): 81-91
La-Perna, Rafael 2005: Tube-dwelling in Gastrochaena dubia (Bivalvia): ecological requirements, functional morphology and structure of the crypt. Bollettino della Societa Paleontologica Italiana 44(2): 145-154
Lu, X.; Zhu, H. 2005: Tube-gel digestion: a novel proteomic approach for high throughput analysis of membrane proteins. Molecular and Cellular Proteomics: Mcp 4(12): 1948-1958
Gendron, R.L.; Good, W.V.; Miskiewicz, E.; Tucker, S.; Phelps, D.L.; Paradis, H. 2006: Tubedown-1 (Tbdn-1) suppression in oxygen-induced retinopathy and in retinopathy of prematurity. Molecular Vision 12: 108-116
Cheng, G.; Zhang, Y.; Zhang, X.; Tang, H.-F.; Cao, W.-D.; Gao, D.-K.; Wang, X.-L. 2006: Tubeimoside V (1), a new cyclic bisdesmoside from tubers of Bolbostemma paniculatum, functions by inducing apoptosis in human glioblastoma U87MG cells. Bioorganic and Medicinal Chemistry Letters 16(17): 4575-4580
Gupta, N.P.; Kesarwani, P.; Goel, R.; Aron, M. 2005: Tubeless percutaneous nephrolithotomy. A comparative study with standard percutaneous nephrolithotomy. Urologia Internationalis 74(1): 58-61
Borin, J.F.; Sala, L.G.; Eichel, L.; McDougall, E.M.; Clayman, R.V. 2005: Tubeless percutaneous nephrolithotomy using hemostatic gelatin matrix. Journal of Endourology 19(6): 614-617; Discussion 617
Werger, M.J.A.; Huber, H. 2006: Tuber size variation and organ preformation constrain growth responses of a spring geophyte. Oecologia 147(3): 396-405
Cunningham, A.F.; Ashton, P.R.; Spreadbury, C.L.; Lammas, D.A.; Craddock, R.; Wharton, C.W.; Wheeler, P.R. 2004: Tubercle bacilli generate a novel cell wall-associated pigment after long-term anaerobic culture. Fems Microbiology Letters 235(1): 191-198
Raina, U.K.; Jain, S.; Monga, S.; Arora, R.; Mehta, D.K. 2004: Tubercular preseptal cellulitis in children: a presenting feature of underlying systemic tuberculosis. Ophthalmology 111(2): 291-296
Sinha, M.; Chacko, K.N.; Kekre, N.S.; Gopalakrishnan, G. 2005: Tubercular ureteric strictures. Jpma. Journal of the Pakistan Medical Association 55(10): 414-416
Shah, S.M.; Ross, A.G.; Chotani, R.; Arif, A.A.; Neudorf, C. 2006: Tuberculin reactivity among health care workers in nonhospital settings. American Journal of Infection Control 34(6): 338-342
Mahadevan, B.; Mahadevan, S.; Serane, V.Tiroumourougane.; Narasimhan, R. 2005: Tuberculin reactivity in tuberculous meningitis. Indian Journal of Pediatrics 72(3): 213-215
Leung, C.C.; Yew, W.W.; Tam, C.M.; Chan, C.K.; Chang, K.C.; Law, W.S.; Lee, S.N.; Wong, M.Y.; Au, K.F. 2005: Tuberculin response in BCG vaccinated schoolchildren and the estimation of annual risk of infection in Hong Kong. Thorax 60(2): 124-129
Dogan, E.; Erkoc, R.; Sayarlioglu, H.; Uzun, K. 2005: Tuberculin skin test results and the booster phenomenon in two-step tuberculin skin testing in hemodialysis patients. Renal Failure 27(4): 425-428
Inselman, L.S. 2003: Tuberculin skin testing and interpretation in children. Pediatric Asthma Allergy and Immunology 16(4): 225-235
Reznik, M.; Ozuah, P.O. 2006: Tuberculin skin testing in children. Emerging Infectious Diseases 12(5): 725-728
Sester, M.; Sester, U.; Clauer, P.; Heine, G.; Mack, U.; Moll, T.; Sybrecht, G.W.; Lalvani, A.; Köhler, H. 2004: Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients. Kidney International 65(5): 1826-1834
Visco-Comandini, U.; Longo, B.; Cuzzi, T.; Paglia, M.Grazia.; Antonucci, G. 2004: Tuberculoid leprosy in a patient with AIDS: a manifestation of immune restoration syndrome. Scandinavian Journal of Infectious Diseases 36(11-12): 881-883
De-Seze, J.; Deligne, L.; Defebvre, L.; Ferriby, D.; Charpentier, P.; Stojkovic, T.; Savage, C.; Pruvo, J.P.; Destee, A.; Vermersch, P. 2004: Tuberculose neuro-meningee : apport de la methode par amplification genique dans le diagnostic. Revue Neurologique (Paris) 160(4 Part 1): 413-418
Margery, J.; Dot, J.M.; Bonnichon, A.; Bonnet, P.M.; Vaylet, F.; Pons, F.; Hardy, K.; Guigay, J.; Jancovici, R.; L'her, P. 2004: Tuberculose pulmonaire active revelee par un pneumothorax spontane. Medecine et Armees 32(2): 169-171
Amdekar, Y.K. 2005: Tuberculosis -- persistent threat to human health. Indian Journal of Pediatrics 72(4): 333-338
Miziara, I.D. 2005: Tuberculosis affecting the oral cavity in Brazilian HIV-infected patients. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics 100(2): 179-182
Mercadal, L.; Foltz, V.; Isnard-Bagnis, C.; Ourahma, S.; Deray, G. 2005: Tuberculosis after conversion from azathioprine to mycophenolate mofetil in a long-term renal transplant recipient. Transplantation Proceedings 37(10): 4241-4243
Schneider, E. 2005: Tuberculosis among American Indians and Alaska Natives in the United States, 1993-2002. American Journal of Public Health 95(5): 873-880
Lawn, S.D.; Badri, M.; Wood, R. 2005: Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort. Aids 19(18): 2109-2116
Hosoglu, S.; Tanrikulu, A.Cetin.; Dagli, C.; Akalin, S. 2005: Tuberculosis among health care workers in a short working period. American Journal of Infection Control 33(1): 23-26
Aliyu, M.H.; Salihu, H.M. 2003: Tuberculosis and HIV disease: two decades of a dual epidemic. Wiener Klinische Wochenschrift 115(19-20): 685-697
Haddad, M.B.; Wilson, T.W.; Ijaz, K.; Marks, S.M.; Moore, M. 2005: Tuberculosis and homelessness in the United States, 1994-2003. JAMA 293(22): 2762-2766
Herer, B. 2005: Tuberculosis and music: A case report and review of clinical, epidemiologic, and cultural factors. Medical Problems of Performing Artists 20(3): 131-134
TeWaternaude, J.M.; Ehrlich, R.I.; Churchyard, G.J.; Pemba, L.; Dekker, K.; Vermeis, M.; White, N.W.; Thompson, M.L.; Myers, J.E. 2006: Tuberculosis and silica exposure in South African gold miners. Occupational and Environmental Medicine 63(3): 187-192
Greco, P.; Vaglio, A.; Corradi, D.; Cobelli, R.; Zompatori, M.; Buzio, C. 2005: Tuberculosis as a trigger of retroperitoneal fibrosis. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 41(7): E72-E75
Yokoyama, T.; Sato, R.; Rikimaru, T.; Hirai, R.; Aizawa, H. 2005: Tuberculosis associated with gastrectomy. Journal of Infection and Chemotherapy: Official Journal of the Japan Society of ChemoTherapy 10(5): 299-302
Druszczyńska, M.; Strapagiel, D.; Kwiatkowska, S.; Kowalewicz-Kulbat, M.; Rózalska, B.; Chmiela, M.; Rudnicka, Wława. 2006: Tuberculosis bacilli still posing a threat. Polymorphism of genes regulating anti-mycobacterial properties of macrophages. Polish Journal of Microbiology 55(1): 7-12
Caldeira, Z.M.R.; Sant'Anna, C.C.; Aidé, M.Abdom. 2004: Tuberculosis contact tracing among children and adolescents, Brazil. Revista de Saude Publica 38(3): 339-345
Lienhardt, C.; Ogden, J.A. 2004: Tuberculosis control in resource-poor countries: have we reached the limits of the universal paradigm?. Tropical Medicine and International Health: Tm and Ih 9(7): 833-841
Behr, M.A. 2004: Tuberculosis due to multiple strains: a concern for the patient? a concern for tuberculosis control?. American Journal of Respiratory and Critical Care Medicine 169(5): 554-555
Mardassi, H.; Namouchi, A.; Haltiti, R.; Zarrouk, M.; Mhenni, B.; Karboul, A.; Khabouchi, N.; Gey van Pittius, N.C.; Streicher, E.M.; Rauzier, J.; Gicquel, B.; Dellagi, K. 2005: Tuberculosis due to resistant Haarlem strain, Tunisia. Emerging Infectious Diseases 11(6): 957-961
Pehme, L.; Hollo, V.; Rahu, M.; Altraja, A. 2005: Tuberculosis during fundamental societal changes in Estonia with special reference to extrapulmonary manifestations. Chest 127(4): 1289-1295
Borgdorff, M.W.; van der Werf, M.J.; de Haas, P.E.W.; Kremer, K.; van Soolingen, D. 2005: Tuberculosis elimination in the Netherlands. Emerging Infectious Diseases 11(4): 597-602
Arcondo, M.F.; Cornistein, W.; La-Torre, F.; Di-Franco, E.; Wachs, A.; Frider, B. 2004: Tuberculosis endomedular en HIV. Reporte de un caso. Prensa Medica Argentina 91(10): 732-734
Currie, C.S.M.; Williams, B.G.; Cheng, R.C.H.; Dye, C. 2003: Tuberculosis epidemics driven by HIV: is prevention better than cure?. Aids 17(17): 2501-2508
Mohan, A.K.; Coté, T.R.; Block, J.A.; Manadan, A.M.; Siegel, J.N.; Braun, M.M. 2004: Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 39(3): 295-299
Girardi, E.; Antonucci, G.; Vanacore, P.; Palmieri, F.; Matteelli, A.; Iemoli, E.; Carradori, S.; Salassa, B.; Pasticci, M.B.; Raviglione, M.C.; Ippolito, G. 2004: Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy. European Respiratory Journal 24(1): 11-17
Nissapatorn, V.; Kuppusamy, I.; Sim, B.L.H.; Quek, K.F.; Khairul Anuar, A. 2005: Tuberculosis in HIV/AIDS patients: a Malaysian experience. Southeast Asian Journal of Tropical Medicine and Public Health 36(4): 946-953
Howie, S.; Voss, L.; Baker, M.; Calder, L.; Grimwood, K.; Byrnes, C. 2005: Tuberculosis in New Zealand, 1992-2001: a resurgence. Archives of disease in childhood 90(11): 1157-1161
Sayarlioglu, M.; Inanc, M.; Kamali, S.; Cefle, A.; Karaman, O.; Gul, A.; Ocal, L.; Aral, O.; Konice, M. 2004: Tuberculosis in Turkish patients with systemic lupus erythematosus: increased frequency of extrapulmonary localization. Lupus 13(4): 274-278
Sabbatani, S.; Manfredi, R.; Legnani, G.; Chiodo, F. 2004: Tuberculosis in a metropolitan area of northern Italy: epidemiological trends and public health concerns. European Journal of Epidemiology 19(5): 501-503
Armbrust, W.; Kamphuis, S.S.M.; Wolfs, T.W.F.; Fiselier, T.J.W.; Nikkels, P.G.; Kuis, W.; Wulffraat, N.M. 2004: Tuberculosis in a nine-year-old girl treated with infliximab for systemic juvenile idiopathic arthritis. Rheumatology 43(4): 527-529
Alcaïs, A.; Fieschi, C.; Abel, L.; Casanova, J.-L. 2005: Tuberculosis in children and adults: two distinct genetic diseases. Journal of Experimental Medicine 202(12): 1617-1621
Dahle, U.R.; Nordtvedt, S.; Winje, B.A.; Mannsaaker, T.; Heldal, E.; Sandven, P.; Grewal, H.M.S.; Caugant, D.A. 2005: Tuberculosis in contacts need not indicate disease transmission. Thorax 60(2): 136-137
Lyashchenko, K.P.; Greenwald, R.; Esfandiari, J.; Olsen, J.H.; Ball, R.; Dumonceaux, G.; Dunker, F.; Buckley, C.; Richard, M.; Murray, S.; Payeur, J.B.; Andersen, P.; Pollock, J.M.; Mikota, S.; Miller, M.; Sofranko, D.; Waters, W.R. 2006: Tuberculosis in elephants: antibody responses to defined antigens of Mycobacterium tuberculosis, potential for early diagnosis, and monitoring of treatment. Clinical and Vaccine Immunology: Cvi 13(7): 722-732
Driver, C.R.; Stricof, R.L.; Granville, K.; Munsiff, S.S.; Savranskaya, G.; Kearns, C.; Christie, A.; Oxtoby, M. 2005: Tuberculosis in health care workers during declining tuberculosis incidence in new York State. American Journal of Infection Control 33(9): 519-526
Mouchet, F.; Hansen, V.ér.; Van Herreweghe, I.; Vandenberg, O.; Van Hesse, R.ég.; Gérard, M.èl.; Toppet, M.èl.; Wanlin, M.; Toppet, V.ér.; Casimir, G.; Haumont, D.; Levy, J. 2004: Tuberculosis in healthcare workers caring for a congenitally infected infant. Infection Control and Hospital Epidemiology 25(12): 1062-1066
Lee, J.; Lee, M.H.; Kim, W.S.; Kim, K.; Park, S.H.; Lee, S.-H.; Lee, K.-E.; Park, J.; Park, J.O.; Jung, C.W.; Im, Y.-H.; Kang, W.K.; Park, K. 2004: Tuberculosis in hematopoietic stem cell transplant recipients in Korea. International Journal of Hematology 79(2): 185-188
Guwatudde, D.; Nakakeeto, M.; Jones-Lopez, E.C.; Maganda, A.; Chiunda, A.; Mugerwa, R.D.; Ellner, J.J.; Bukenya, G.; Whalen, C.C. 2003: Tuberculosis in household contacts of infectious cases in Kampala, Uganda. American Journal of Epidemiology 158(9): 887-898
Bravo, C.; Roldán, J.; Roman, A.; Degracia, J.; Majo, J.; Guerra, J.; Monforte, Víctor.; Vidal, R.; Morell, F. 2005: Tuberculosis in lung transplant recipients. Transplantation 79(1): 59-64
Atasever, A.; Bacakoglu, F.; Toz, H.; Basoglu, O.Kacmaz.; Duman, S.; Basak, K.; Guzelant, A.; Sayiner, A. 2005: Tuberculosis in renal transplant recipients on various immunosuppressive regimens. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 20(4): 797-802
Matuck, T.A.; Brasil, P.; Alvarenga, M.d.F.át.A.C.; Morgado, L.; Rels, M.D.; da Costa, A.C.P.; Araújo, M.; Rodrigues, M.E.; de Carvalho, D.d.B.M. 2004: Tuberculosis in renal transplants in Rio de Janeiro. Transplantation Proceedings 36(4): 905-906
Griffin, J.F.T.; Rodgers, C.R.; Liggett, S.; Mackintosh, C.G. 2006: Tuberculosis in ruminants: characteristics of intra-tonsilar Mycobacterium bovis infection models in cattle and deer. Tuberculosis 86(6): 404-418
Akan, H.; Arslan, O.; Akan, O.A. 2006: Tuberculosis in stem cell transplant patients. Journal of Hospital Infection 62(4): 421-426
Mok, M.Y.; Lo, Y.; Chan, T.M.; Wong, W.S.; Lau, C.S. 2005: Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy. Journal of Rheumatology 32(4): 609-615
Nguyen, D.; Proulx, J.-F.ço.; Westley, J.; Thibert, L.; Dery, S.; Behr, M.A. 2003: Tuberculosis in the Inuit community of Quebec, Canada. American Journal of Respiratory and Critical Care Medicine 168(11): 1353-1357
Torre-Cisneros, J.; Castón, J.José.; Moreno, J.; Rivero, A.; Vidal, E.; Jurado, R.; Kindelán, Jé.María. 2004: Tuberculosis in the transplant candidate: importance of early diagnosis and treatment. Transplantation 77(9): 1376-1380
Yu, M-Chih.; Bai, K-Jen.; Chang, J-Hwa.; Lee, C-Nin. 2004: Tuberculosis incidence and mortality in aboriginal areas of Taiwan, 1997-2001. Journal of the Formosan Medical Association 103(11): 817-823
Verver, S.; van Loenhout-Rooyackers, J.H.; Bwire, R.; Annee-van Bavel, J.A.C.M.; de Lange, H.J.M.; van Gerven, P.J.H.J.; Borgdorff, M.W. 2005: Tuberculosis infection in children who are contacts of immigrant tuberculosis patients. European Respiratory Journal 26(1): 126-132
Turk, A.; Angst, F.; Steffen, R. 2003: Tuberculosis infection notification in Swiss medical students during their clinical electives. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 7(4): 268-273
Sartori, M.-Veronica; Galgano, A.; Luis, A.; Draghi, S.; Jaritos, J., D. 2004: Tuberculosis laringea. Prensa Medica Argentina 91(7): 491-496
Govor, O.V. 2004: Tuberculosis morbidity in the maritime territory. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 1: 77-78
Thyssen, J.P.; Lillebaek, T.; Andersen, P.H.; Kok-Jensen, A.; Thomsen, V.O. 2004: Tuberculosis not verified by culture in a low incidence country. Scandinavian Journal of Infectious Diseases 36(11-12): 807-810
Gupta, S.K.; Mohindra, S.; Sharma, B.S.; Gupta, R.; Chhabra, R.; Mukherjee, K.K.; Tewari, M.K.; Pathak, A.; Khandelwal, N.; Suresh, N.M.; Khosla, V.K. 2006: Tuberculosis of the craniovertebral junction: is surgery necessary?. Neurosurgery 58(6): 1144-50; Discussion 1144-50
Muttarak, M.; ChiangMai, W.N.; Lojanapiwat, B. 2005: Tuberculosis of the genitourinary tract: imaging features with pathological correlation. Singapore Medical Journal 46(10): 568-74; Quiz 575
Husen, Y.A.; Nadeem, N.; Aslam, F.; Shah, M.Ali. 2006: Tuberculosis of the scapula. Jpma. Journal of the Pakistan Medical Association 56(7): 336-338
Meher, R.; Singh, I.; Raj, A. 2003: Tuberculosis of zygoma. International Journal of Pediatric Otorhinolaryngology 67(12): 1383-1385
Repetto, S.; D'alessandro, D.; Amado, V.; Gardella, A.M.; Cisneros, J.C.; Ahumada, J.C.; Tarruella, M.C.; Baldomir, C. 2004: Tuberculosis osea multifocal en un paciente inmunocompetente. Prensa Medica Argentina 91(7): 500-504
Chong, V.H.; Rajendran, N. 2005: Tuberculosis peritonitis in Negara Brunei Darussalam. Annals of the Academy of Medicine Singapore 34(9): 548-552
Adsuar, N.; Blanchette, H.; Kilchevsky, E. 2004: Tuberculosis peritonitis mimicking ovarian cancer in a 20-year-old woman. A case report. Journal of Reproductive Medicine 49(1): 52-54
Lu, W.; Wai, C.T.; Da Costa, M.; Tambyah, P.A.; Prabhakaran, K.; Lee, K.H. 2005: Tuberculosis post-liver transplantation: a rare but complicated disease. Annals of the Academy of Medicine Singapore 34(2): 213-215
Saleemi, S.; Khalid, M.; Zeitouni, M.; Al-Dammas, S. 2004: Tuberculosis presenting as endobronchial tumor. Saudi Medical Journal 25(8): 1103-1105
Roberts, C.A.; Lobato, M.N.; Bazerman, L.B.; Kling, R.; Reichard, A.A.; Hammett, T.M. 2006: Tuberculosis prevention and control in large jails: a challenge to tuberculosis elimination. American Journal of Preventive Medicine 30(2): 125-130
Thrupp, L.; Bradley, S.; Smith, P.; Simor, A.; Gantz, N.; Crossley, K.; Loeb, M.; Strausbaugh, L.; Nicolle, L. 2004: Tuberculosis prevention and control in long-term-care facilities for older adults. Infection Control and Hospital Epidemiology 25(12): 1097-1108
Sackoff, J.E.; Pfeiffer, M.R.; Driver, C.R.; Streett, L.S.; Munsiff, S.S.; DeHovitz, J.A. 2006: Tuberculosis prevention for non-US-born pregnant women. American Journal of Obstetrics and Gynecology 194(2): 451-456
Kandula, N.R.; Dworkin, M.S.; Carroll, M.R.; Lauderdale, D.S. 2004: Tuberculosis prevention in Mexican immigrants: limitations of short-course therapy. American Journal of Preventive Medicine 26(2): 163-166
Saraiya, M.; Cookson, S.T.; Tribble, P.; Silk, B.; Cass, R.; Poonja, S.; Walting, M.; Howland, N.; Paz, E.A.; Cochran, J.; Moser, K.S.; Oxtoby, M.J.; Binkin, N.J. 2002: Tuberculosis screening among foreign-born persons applying for permanent US residence. American Journal of Public Health 92(5): 826-829
Kammerer, J.S.; McNabb, S.J.N.; Becerra, J.E.; Rosenblum, L.; Shang, N.; Iademarco, M.F.; Navin, T.R. 2005: Tuberculosis transmission in nontraditional settings: a decision-tree approach. American Journal of Preventive Medicine 28(2): 201-207
Jasmer, R.M.; Seaman, C.B.; Gonzalez, L.C.; Kawamura, L.M.; Osmond, D.H.; Daley, C.L. 2004: Tuberculosis treatment outcomes: directly observed therapy compared with self-administered therapy. American Journal of Respiratory and Critical Care Medicine 170(5): 561-566
Faustini, A.; Hall, A.J.; Perucci, C.A. 2005: Tuberculosis treatment outcomes in Europe: a systematic review. European Respiratory Journal 26(3): 503-510
Reed, S.; Lobet, Y. 2005: Tuberculosis vaccine development; from mouse to man. Microbes and Infection 7(5-6): 922-931
Drobniewski, F.A.; Balabanova, Y.M.; Ruddy, M.C.; Graham, C.; Kuznetzov, S.I.; Gusarova, G.I.; Zakharova, S.M.; Melentyev, A.S.; Fedorin, I.M. 2005: Tuberculosis, HIV seroprevalence and intravenous drug abuse in prisoners. European Respiratory Journal 26(2): 298-304
Ross, J.J.; Orwell, G. 2005: Tuberculosis, bronchiectasis, and infertility: what ailed George Orwell?. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 41(11): 1599-1603
Tobin, M.J. 2004: Tuberculosis, lung infections, interstitial lung disease, social issues and journalology in AJRCCM 2003. American Journal of Respiratory and Critical Care Medicine 169(2): 288-300
Nemery, B.; Yew, W.Wai.; Albert, R.; Brun-Buisson, C.; Macnee, W.; Martinez, F.J.; Angus, D.C.; Abraham, E. 2005: Tuberculosis, nontuberculous lung infection, pleural disorders, pulmonary function, respiratory muscles, occupational lung disease, pulmonary infections, and social issues in AJRCCM in 2004. American Journal of Respiratory and Critical Care Medicine 171(6): 554-562
Chien, C-Chiang.; Chiou, T-Jye.; Lee, M-Yang.; Hsiao, L-Tsai.; Kwang, W-Kang. 2004: Tuberculosis-associated hemophagocytic syndrome in a hemodialysis patient with protracted fever. International Journal of Hematology 79(4): 334-336
Kimura, H.; Yoshizumi, M.; Iijima, M.; Tsukagoshi, T.; Nishimura, T.; Kato, M.; Morita, Y.; Tanaka, R.; Kozawa, K.; Fujita, M.; Kojima, M.; Minakami, H. 2006: Tuberculosis-like peritonitis due to an atypical Mycobacterium infection in a Japanese woman. Japanese Journal of Infectious Diseases 59(3): 189-191
Yepes, J.F.; Sullivan, J.; Pinto, A. 2004: Tuberculosis: medical management update. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics 98(3): 267-273
Agarwal, P.; Sharma, D.; Agarwal, A.; Agarwal, V.; Tandon, A.; Baghel, K.D.; Raina, V.K. 2004: Tuberculous appendicitis in India. Tropical Doctor 34(1): 36-38
Vidal, J.E.; Penalva de Oliveira, A.C.; Bonasser Filho, F.; Schiavon Nogueira, R.; Dauar, R.F.; Leite, A.G.; Lins, D.L.M.; Coelho, J.F.G.S. 2005: Tuberculous brain abscess in AIDS patients: report of three cases and literature review. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 9(4): 201-207
Al-Ghazo, M.A.; Bani-Hani, K.E.; Amarin, Z.O. 2005: Tuberculous epididymitis and fertility in North Jordan. Saudi Medical Journal 26(8): 1212-1215
Ishizu, K.; Hirata, H.; Yano, S.; Naito, K.; Furuya, T.; Muratani, T.; Kobayashi, T. 2003: Tuberculous epididymitis caused by intravesical BCG therapy: a case report. Hinyokika Kiyo. Acta Urologica Japonica 49(9): 539-542
Guler, Z.Mujgan.; Kanbay, A.; Kanbay, M.; Ciftci, B.; Erdogan, Y. 2006: Tuberculous epididymitis presenting with Addison's disease: a rare case. Journal of the National Medical Association 98(7): 1175-1176
Liu, H-Yun.; Fu, Y-Tzueng.; Wu, C-Jiunn.; Sun, G-Huan. 2005: Tuberculous epididymitis: a case report and literature review. Asian Journal of Andrology 7(3): 329-332
Chen, F.; Brook, G.; Williams, G.; Murphy, S. 2004: Tuberculous epididymo-orchitis presenting within the setting of a sexually transmitted disease clinic. Sexually Transmitted Diseases 31(3): 163-165
Volkman, H.E.; Clay, H.; Beery, D.; Chang, J.C.W.; Sherman, D.R.; Ramakrishnan, L. 2004: Tuberculous granuloma formation is enhanced by a mycobacterium virulence determinant. Plos Biology 2(11): E367
Rathinam, S.R.; Rao, N.A. 2004: Tuberculous intraocular infection presenting with pigmented hypopyon: a clinicopathological case report. British Journal of Ophthalmology 88(5): 721-722
Hayashi, M.; Yamawaki, I.; Okajima, K.; Tomimatsu, M.; Ohkawa, S-Ichiro. 2004: Tuberculous liver abscess not associated with lung involvement. Internal Medicine 43(6): 521-523
Karande, S.; Gupta, V.; Kulkarni, M.; Joshi, A.; Rele, M. 2005: Tuberculous meningitis and HIV. Indian Journal of Pediatrics 72(9): 755-760
van den Bos, F.; Terken, M.; Ypma, L.; Kimpen, J.L.L.; Nel, E.D.; Schaaf, H.S.; Schoeman, J.F.; Donald, P.R. 2004: Tuberculous meningitis and miliary tuberculosis in young children. Tropical Medicine and International Health: Tm and Ih 9(2): 309-313
Huang, S-Ming.; Chen, C-Chin.; Chiu, P-Chin.; Cheng, M-Fang.; Chiu, C-Lan.; Hsieh, K-Sheng. 2004: Tuberculous meningitis complicated with hydrocephalus and cerebral salt wasting syndrome in a three-year-old boy. Pediatric Infectious Disease Journal 23(9): 884-886
Kumar, R.; Dwivedi, A.; Kumar, P.; Kohli, N. 2005: Tuberculous meningitis in BCG vaccinated and unvaccinated children. Journal of Neurology Neurosurgery and Psychiatry 76(11): 1550-1554
Ertekin, V.; Alp, H.; Altinkaynak, S.; Selimoğlu, M.A. 2005: Tuberculous meningitis in Turkish children: an evaluation of 38 cases. Tropical Doctor 35(3): 183-184
Abdelmalek, R.; Kanoun, F.; Kilani, B.; Tiouiri, Hène.; Zouiten, F.; Ghoubantini, A.; Chaabane, T.Ben. 2006: Tuberculous meningitis in adults: MRI contribution to the diagnosis in 29 patients. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 10(5): 372-377
Sütlaş, P.N.; Unal, A.; Forta, H.; Senol, S.; Kirbaş, D. 2003: Tuberculous meningitis in adults: review of 61 cases. Infection 31(6): 387-391
Jebaraj, P.; Oommen, M.; Thopuram, P.; Jacob, K.S. 2005: Tuberculous meningitis masked by delirium in an alcohol-dependent patient: a case report. Acta Psychiatrica Scandinavica 112(6): 478-9; Discussion 480
Moghtaderi, A.; Alavi-Naini, R.; Rahimi-Movaghar, V. 2006: Tuberculous myelopathy: current aspects of neurologic sequels in the southeast of Iran. Acta Neurologica Scandinavica 113(4): 267-272
Combalia, A.; Sastre, S.; Esteban, P. 2004: Tuberculous osteomyelitis of the knee. Archives of Orthopaedic and Trauma Surgery 124(10): 708-710
Esteban, P.L.; Soriano, A.; Tomás, X.; Quintana, L.; García-Ramiro, Sán. 2006: Tuberculous osteomyelitis of the knee: a case report. Archives of Orthopaedic and Trauma Surgery 126(9): 631-633
Buyukbebeci, O.; Karakurum, G.; Guleç, A.; Erbagci, A. 2004: Tuberculous osteomyelitis of the lumbosacral region: a spinal epidural abscess with presacral extension. Archives of Orthopaedic and Trauma Surgery 124(5): 346-348
Nicolau, Y.; Northrop, C.; Eavey, R. 2006: Tuberculous otitis in infants: temporal bone histopathology and clinical extrapolation. Otology and Neurotology: Official Publication of the American Otological Society American Neurotology Society and European Academy of Otology and Neurotology 27(5): 667-671
Nishiike, S.; Irifune, M.; Doi, K.; Osaki, Y.; Kiuchi, N. 2003: Tuberculous otitis media: clinical aspects of 12 cases. Annals of Otology Rhinology and Laryngology 112(11): 935-938
Lee, I-Kit.; Liu, J-Wei. 2005: Tuberculous parotitis: case report and literature review. Annals of Otology Rhinology and Laryngology 114(7): 547-551
Moritani, Y.; Ishii, T.; Takiue, T. 2005: Tuberculous perianal ulcer - A case report. Journal of the Japan Society of Coloproctology 58(4): 211-217
Cherian, G.; Uthaman, B.; Salama, A.; Habashy, A.G.; Khan, N.A.; Cherian, J.M. 2004: Tuberculous pericardial effusion: features, tamponade, and computed tomography. Angiology 55(4): 431-440
Mayosi, B.M.; Burgess, L.J.; Doubell, A.F. 2005: Tuberculous pericarditis. Circulation 112(23): 3608-3616
Makiyama, A.; Okuyama, Y.; Okajima, T.; Fujimoto, S. 2003: Tuberculous peritonitis. Journal of Gastroenterology 38(12): 1167-1170
Hung, Y-Min.; Chan, H-Hung.; Chung, H-Min. 2004: Tuberculous peritonitis in different dialysis patients in Southern Taiwan. American Journal of Tropical Medicine and Hygiene 70(5): 532-535
Wu, J-Feng.; Li, H-Jung.; Lee, P-Ing.; Ni, Y-Hsuan.; Yu, S-Chang.; Chang, M-Hwei. 2003: Tuberculous peritonitis mimicking peritonitis carcinomatosis: a case report. European Journal of Pediatrics 162(12): 853-855
Satokawa, H.; Takahasi, K.; Hoshino, Y.; Yokoyama, H.; Saito, T.; Kazuma, H. 2004: Tuberculous pseudoaneurysm of the celiac artery. A case report. International Angiology: a Journal of the International Union of Angiology 23(1): 85-88
Leccese, K.; Ferreira, Jé.; Delorme, J.; Montreuil, B. 2006: Tuberculous pseudoaneurysm of the femoral artery complicated by cutaneous tuberculosis of the foot: a case report. Journal of Vascular Surgery 44(3): 654-657
Chu, C.-K.; Yang, T.-L.; Tan, C.-T. 2004: Tuberculous pyomyositis of the temporal muscle in a nonimmunocompromised woman: diagnosis by sonography. Journal of Laryngology and Otology 118(1): 59-61
Chotmongkol, V.; Kitkuandee, A.; Limpawattana, P. 2005: Tuberculous radiculomyelitis (arachnoiditis) associated with tuberculous meningitis. Southeast Asian Journal of Tropical Medicine and Public Health 36(3): 722-724
Keleş, Işik.; Aydin, Gülümser.; Kitay, O.L.; Orkun, S. 2004: Tuberculous sacroiliitis: a case report. Rheumatology International 24(5): 312-314
Chang, M-Chau.; Wu, H.Ta.H.; Lee, C-Han.; Liu, C-Lin.; Chen, T-Hsiung. 2006: Tuberculous spondylitis and pyogenic spondylitis: comparative magnetic resonance imaging features. Spine 31(7): 782-788
Crespo, M.; Pigrau, C.; Flores, X.; Almirante, B.; Falco, V.; Vidal, R.; Pahissa, A. 2004: Tuberculous trochanteric bursitis: report of 5 cases and literature review. Scandinavian Journal of Infectious Diseases 36(8): 552-558
Bassiouni, H.; Asgari, S.; Stolke, D. 2006: Tuberculum sellae meningiomas: functional outcome in a consecutive series treated microsurgically. Surgical Neurology 66(1): 37-44; Discussion: 44-45
Jiang, W.G.; Sampson, J.; Martin, T.A.; Lee-Jones, L.; Watkins, G.; Douglas-Jones, A.; Mokbel, K.; Mansel, R.E. 2005: Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes. European Journal of Cancer 41(11): 1628-1636
Jóźwiak, S.; Kwiatkowski, D.; Kotulska, K.; Larysz-Brysz, M.; Lewin-Kowalik, J.; Grajkowska, Wława.; Roszkowski, M. 2004: Tuberin and hamartin expression is reduced in the majority of subependymal giant cell astrocytomas in tuberous sclerosis complex consistent with a two-hit model of pathogenesis. Journal of Child Neurology 19(2): 102-106
Rosner, M.; Hengstschläger, M. 2004: Tuberin binds p27 and negatively regulates its interaction with the SCF component Skp2. Journal of Biological Chemistry 279(47): 48707-48715
Freilinger, A.; Rosner, M.; Hengstschläger, M. 2006: Tuberin negatively affects BCL-2's cell survival function. Amino Acids 30(4): 391-396
Schuchardt, V.; Prange, H. 2005: Tuberkulose meningitis. Intensivmedizin und Notfallmedizin 42(1): 9-15
LaBuda, C.J.; Usdin, T.B. 2004: Tuberoinfundibular peptide of 39 residues decreases pain-related affective behavior. Neuroreport 15(11): 1779-1782
LaBuda, C.J.; Dobolyi, A.; Usdin, T.B. 2004: Tuberoinfundibular peptide of 39 residues produces anxiolytic and antidepressant actions. Neuroreport 15(5): 881-885
Ross, G.; Engel, P.; Abdallah, Y.; Kummer, W.; Schluter, K.D. 2005: Tuberoinfundibular peptide of 39 residues: a new mediator of cardiac function via nitric oxide production in the rat heart. Endocrinology 146(5): 2221-2228
Yates, J.R.W. 2006: Tuberous sclerosis. European Journal of Human Genetics: Ejhg 14(10): 1065-1073
Weiner, H.L. 2004: Tuberous sclerosis and multiple tubers: localizing the epileptogenic zone. Epilepsia 45(Suppl 4): 41-42
Laass, M.W.; Spiegel, M.; Jauch, A.; Hahn, G.; Rupprecht, E.; Vogelberg, C.; Bartsch, O.; Huebner, A. 2004: Tuberous sclerosis and polycystic kidney disease in a 3-month-old infant. Pediatric Nephrology 19(6): 602-608
Henske, E.P. 2005: Tuberous sclerosis and the kidney: from mesenchyme to epithelium, and beyond. Pediatric Nephrology 20(7): 854-857
Suryavanshi, N.M.; Kashyape, S.S.; Kashyape, P.; Phalke, V. 2004: Tuberous sclerosis complex. Indian Journal of Pediatrics 71(7): 659
Birchenall-Roberts, M.C.; Fu, T.; Bang, O.-S.; Dambach, M.; Resau, J.H.; Sadowski, C.L.; Bertolette, D.C.; Lee, H.-J.; Kim, S.-J.; Ruscetti, F.W. 2004: Tuberous sclerosis complex 2 gene product interacts with human SMAD proteins. a molecular link of two tumor suppressor pathways. Journal of Biological Chemistry 279(24): 25605-25613
Jansen, F.E.; van Nieuwenhuizen, O.; van Huffelen, A.C.; Bourneville, D.és.é M.; Pringle, J.J. 2004: Tuberous sclerosis complex and its founders. Journal of Neurology Neurosurgery and Psychiatry 75(5): 770
Winterkorn, E.B.; Daouk, G.H.; Anupindi, S.; Thiele, E.A. 2006: Tuberous sclerosis complex and renal angiomyolipoma: case report and review of the literature. Pediatric Nephrology 21(8): 1189-1193
Caprez, C.; Walling, A.D.; Reimer, C.M. 2004: Tuberous sclerosis complex in a young woman diagnosed incidentally on the basis of pregnancy ultrasonography. Southern Medical Journal 97(5): 512-515
Vallmanya, F.; Placer, J.; Pou Serradell, A.; Cortadellas, R.; Gelabert-Mas, A. 2006: Tuberous sclerosis complex. Forty-years of follow-up of a patient affected. Archivos Espanoles de Urologia 59(1): 105-107
Wong, V.; Khong, P-Lan. 2006: Tuberous sclerosis complex: correlation of magnetic resonance imaging (MRI) findings with comorbidities. Journal of Child Neurology 21(2): 99-105
Pan, D.; Dong, J.; Zhang, Y.; Gao, X. 2004: Tuberous sclerosis complex: from Drosophila to human disease. Trends in Cell Biology 14(2): 78-85
Connolly, M.B.; Hendson, G.; Steinbok, P. 2006: Tuberous sclerosis complex: a review of the management of epilepsy with emphasis on surgical aspects. Child's Nervous System: Chns: Official Journal of the International Society for Pediatric Neurosurgery 22(8): 896-908
Hengstschläger, M.; Rosner, M.; Fountoulakis, M.; Lubec, G. 2003: Tuberous sclerosis genes regulate cellular 14-3-3 protein levels. Biochemical and Biophysical Research Communications 312(3): 676-683
Ogunrin-Ao; Adeyekun, A.A.; Akhigbe, A.O.; Ofovwe, C.E. 2005: Tuberous sclerosis in a young Nigerian male: A case report and review of the literature. Discovery and Innovation 17(3-4): 122-128
Adhvaryu, K.; Shanbag, P.; Vaidya, M. 2004: Tuberous sclerosis with hypothyroidism and precocious puberty. Indian Journal of Pediatrics 71(3): 273-275
Kwiatkowski, D.J.; Manning, B.D. 2005: Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Human Molecular Genetics 14 Spec No. 2: R251-R258
Kamata, K.; Onuki, H.; Hirota, H.; Yamamoto, Y.; Hayashi, M.; Komiyama, K.; Sato, M.; Ishibashi, M. 2004: Tubiferal A, a backbone-rearranged triterpenoid lactone isolated from the myxomycete Tubifera dimorphotheca, possessing reversal of drug resistance activity. Tetrahedron 60(44): 9835-9839
Midturi, J.; Baker, D.; Winn, R.; Fader, R. 2005: Tubo-ovarian abscess caused by Vibrio vulnificus. Diagnostic Microbiology and Infectious Disease 51(2): 131-133
Canas, A.M.; Holloran-Schwartz, B.; Myles, T. 2004: Tuboovarian abscess 12 years after total abdominal hysterectomy. Obstetrics and Gynecology 104(5 Pt 1): 1039-1041
Daniel, L.; Bardin, N.; Moal, Vérie.; Dignat-George, Fçoise.; Berland, Y.; Figarella-Branger, D. 2005: Tubular CD146 expression in nephropathies is related to chronic renal failure. Nephron. Experimental Nephrology 99(4): E105-E111
Sarioğlu, S.; Sis, B.; Tuncer, C.; Celik, A.; Zeybel, M.; Soylu, A.; Gülay, H. 2004: Tubular CD44 expression in renal allograft biopsies. Transplantation Proceedings 36(1): 92-94
Roald, A.B.; Aukland, K.; Tenstad, O. 2004: Tubular absorption of filtered cystatin-C in the rat kidney. Experimental Physiology 89(6): 701-707
Shahrizaila, N.; Lim, W.S.; Robson, D.K.; Kinnear, W.J.; Wills, A.J. 2006: Tubular aggregate myopathy presenting with acute type Ii respiratory failure and severe orthopnoea. Thorax 61(1): 89-90
Akesson, A.; Lundh, T.; Vahter, M.; Bjellerup, P.; Lidfeldt, J.; Nerbrand, C.; Samsioe, Göran.; Strömberg, U.; Skerfving, S. 2005: Tubular and glomerular kidney effects in Swedish women with low environmental cadmium exposure. Environmental Health Perspectives 113(11): 1627-1631
Cieciura, T.; Urbanowicz, A.; Perkowska-Ptasinska, A.; Nowacka-Cieciura, E.; Tronina, O.; Majchrzak, J.; Baczkowska, T.; Matlosz, B.; Danielewicz, R.; Nazarewski, S.; Durlik, M. 2005: Tubular and glomerular proteinuria in diagnosing chronic allograft nephropathy with relevance to the degree of urinary albumin excretion. Transplantation Proceedings 37(2): 987-990
Kumar, D.; Zimpelmann, J.; Robertson, S.; Burns, K.D. 2004: Tubular and interstitial cell apoptosis in the streptozotocin-diabetic rat kidney. NEPHRON. Experimental Nephrology 96(3): E77-E88
Lee, C.-K.; Jang, K.-T.; Cho, Y.-S. 2005: Tubular apocrine adenoma with syringocystadenoma papilliferum arising from the external auditory canal. Journal of Laryngology and Otology 119(12): 1004-1006
Fernández-Aguilar, S.; Simon, P.; Buxant, F.éd.ér.; Simonart, T.; Noël, J.-C. 2005: Tubular carcinoma of the breast and associated intra-epithelial lesions: a comparative study with invasive low-grade ductal carcinomas. Virchows Archiv: An International Journal of Pathology 447(4): 683-687
Sullivan, T.; Raad, R.Abi.; Goldberg, S.; Assaad, S.I.; Gadd, M.; Smith, B.L.; Powell, S.N.; Taghian, A.G. 2005: Tubular carcinoma of the breast: a retrospective analysis and review of the literature. Breast Cancer Research and Treatment 93(3): 199-205
Vogetseder, A.; Karadeniz, A.; Kaissling, B.; Le Hir, M. 2005: Tubular cell proliferation in the healthy rat kidney. Histochemistry and Cell Biology 124(2): 97-104
Mengel, M.; Jonigk, D.; Marwedel, M.; Kleeberger, W.; Bredt, M.; Bock, O.; Lehmann, U.; Gwinner, W.; Haller, H.; Kreipe, H. 2004: Tubular chimerism occurs regularly in renal allografts and is not correlated to outcome. Journal of the American Society of Nephrology: Jasn 15(4): 978-986
Futrakul, N.; Vongthavarawat, V.; Sirisalipotch, S.; Chairatanarat, T.; Futrakul, P.; Suwanwalaikorn, S. 2005: Tubular dysfunction and hemodynamic alteration in normoalbuminuric type 2 diabetes. Clinical Hemorheology and Microcirculation 32(1): 59-65
Chan, L.Y.Y.; Leung, J.C.K.; Tang, S.C.W.; Choy, C.B.Y.; Lai, K.N. 2005: Tubular expression of angiotensin Ii receptors and their regulation in IgA nephropathy. Journal of the American Society of Nephrology: Jasn 16(8): 2306-2317
De Buck, J.; Pasmans, F.; Van Immerseel, F.; Haesebrouck, F.; Ducatelle, R. 2004: Tubular glands of the isthmus are the predominant colonization site of Salmonella enteritidis in the upper oviduct of laying hens. Poultry Science 83(3): 352-358
Cherdwongcharoensuk, D.; Henrique, R.; Upatham, S.; Pereira, Aónio.Sousa.; Aguas, A.P. 2005: Tubular kidney damage and centrilobular liver injury after intratracheal instillation of dimethyl selenide. Toxicologic Pathology 33(2): 225-229
Van Timmeren, M.M.; Bakker, S.J.L.; Vaidya, V.S.; Bailly, V.; Schuurs, T.A.; Damman, J.; Stegeman, C.A.; Bonventre, J.V.; van Goor, H. 2006: Tubular kidney injury molecule-1 in protein-overload nephropathy. American Journal of Physiology. Renal Physiology 291(2): F456-F464
Yamato, K.; Kaneto, K. 2006: Tubular linear actuators using conducting polymer, polypyrrole. Analytica Chimica Acta 568(1-2): 133-137
Rabaey, K.; Clauwaert, P.; Aelterman, P.; Verstraete, W. 2005: Tubular microbial fuel cells for efficient electricity generation. Environmental Science and Technology 39(20): 8077-8082
Lasaitiene, D.; Chen, Y.; Mildaziene, V.; Nauciene, Z.; Sundelin, B.; Johansson, B.R.; Yano, M.; Friberg, P. 2005: Tubular mitochondrial alterations in neonatal rats subjected to RAS inhibition. American Journal of Physiology. Renal Physiology 290(5): F1260-F1269
Stone, D.A.; Goldstein, R.E. 2004: Tubular precipitation and redox gradients on a bubbling template. Proceedings of the National Academy of Sciences of the United States of America 101(32): 11537-11541
Ojala, R.; Ala-Houhala, M.; Harmoinen, A.P.T.; Luukkaala, T.; Uotila, J.; Tammela, O. 2006: Tubular proteinuria in pre-term and full-term infants. Pediatric Nephrology 21(1): 68-73
Schwedler, S.B.; Guderian, F.; Dämmrich, J.; Potempa, L.A.; Wanner, C. 2003: Tubular staining of modified C-reactive protein in diabetic chronic kidney disease. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 18(11): 2300-2307
Stacchiotti, A.; Ricci, F.; Rezzani, R.; Li Volti, G.; Borsani, E.; Lavazza, A.; Bianchi, R.; Rodella, L.Fabrizio. 2006: Tubular stress proteins and nitric oxide synthase expression in rat kidney exposed to mercuric chloride and melatonin. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 54(10): 1149-1157
Stephenson, D.George. 2006: Tubular system excitability: an essential component of excitation-contraction coupling in fast-twitch fibres of vertebrate skeletal muscle. Journal of Muscle Research and Cell Motility 27(5-7): 259-274
Servais, A.; Lechat, P.; Zahr, N.ël.; Urien, S.; Aymard, G.; Jaudon, M.C.; Deray, G.; Isnard Bagnis, C. 2006: Tubular transporters and clearance of adefovir. European Journal of Pharmacology 540(1-3): 168-174
Nguyen, M.T.; Snodgrass, W.T. 2004: Tubularized incised plate hypospadias reoperation. Journal of Urology 171(6 Pt 1): 2404-6; Discussion 2406
El-Sherbiny, M.T. 2003: Tubularized incised plate repair of distal hypospadias in toilet-trained children: should a stent be left?. Bju International 92(9): 1003-1005
Eliçevik, M.; Tireli, G.ül.; Sander, S. 2004: Tubularized incised plate urethroplasty: 5 years' experience. European Urology 46(5): 655-659; Discussion 659
Al-Hunayan, A.A.; Kehinde, E.O.; Elsalam, M.A.; Al-Mukhtar, R.S. 2003: Tubularized incised plate urethroplasty: modification and outcome. International Urology and Nephrology 35(1): 47-52
Samuel, M.; Wilcox, D.T. 2003: Tubularized incised-plate urethroplasty for distal and proximal hypospadias. Bju International 92(7): 783-785
Sharma, G. 2005: Tubularized-incised plate urethroplasty in adults. Bju International 95(3): 374-376
Lauria, G.; Borgna, M.; Morbin, M.; Lombardi, R.; Mazzoleni, G.; Sghirlanzoni, A.; Pareyson, D. 2004: Tubule and neurofilament immunoreactivity in human hairy skin: markers for intraepidermal nerve fibers. Muscle and Nerve 30(3): 310-316
Kumarasinghe, M.Priyanthi.; Lim, T.Kiat.Hon.; Ooi, C-Jin.; Luman, W.; Tan, S-Yong.; Koh, M. 2006: Tubule neck dysplasia: precursor lesion of signet ring cell carcinoma and the immunohistochemical profile. Pathology 38(5): 468-471
Arola, D.D.; Reprogel, R.K. 2006: Tubule orientation and the fatigue strength of human dentin. Biomaterials 27(9): 2131-2140
Kimura, T.; Watanabe, H.; Iwamatsu, A.; Kaibuchi, K. 2005: Tubulin and CRMP-2 complex is transported via Kinesin-1. Journal of Neurochemistry 93(6): 1371-1382
Madiraju, C.; Edler, M.C.; Hamel, E.; Raccor, B.S.; Balachandran, R.; Zhu, G.; Giuliano, K.A.; Vogt, A.; Shin, Y.; Fournier, J-Hugues.; Fukui, Y.; Brückner, A.M.; Curran, D.P.; Day, B.W. 2005: Tubulin assembly, taxoid site binding, and cellular effects of the microtubule-stabilizing agent dictyostatin. Biochemistry 44(45): 15053-15063
Nolasco, S.; Bellido, J.; Gonçalves, J.ão.; Zabala, J.C.; Soares, H. 2005: Tubulin cofactor a gene silencing in mammalian cells induces changes in microtubule cytoskeleton, cell cycle arrest and cell death. Febs Letters 579(17): 3515-3524
Mershin, A.; Kolomenski, A.A.; Schuessler, H.A.; Nanopoulos, D.V. 2004: Tubulin dipole moment, dielectric constant and quantum behavior: computer simulations, experimental results and suggestions. Bio Systems 77(1-3): 73-85
Sánchez, S.A.; Brunet, J.E.; Jameson, D.M.; Lagos, R.; Monasterio, O. 2004: Tubulin equilibrium unfolding followed by time-resolved fluorescence and fluorescence correlation spectroscopy. Protein Science: a Publication of the Protein Society 13(1): 81-88
Niu, C.; Smith, D.; Zask, A.; Loganzo, F.; Discafani, C.; Beyer, C.; Greenberger, L.; Ayral-Kaloustian, S. 2004: Tubulin inhibitors. Synthesis and biological activity of HTI-286 analogs with B-segment heterosubstituents. Bioorganic and Medicinal Chemistry Letters 14(16): 4329-4332
Kovacs, P.; Csaba, G. 2006: Tubulin is not posttranslationally modified (acetylated or polyglutamylated) in Tetrahymena macronucleus. Acta Protozoologica 45(2): 205-210
Holtser-Cochav, M.; Divinski, I.; Gozes, I. 2006: Tubulin is the target binding site for NAP-related peptides: ADNF-9, D-NAP, and D-SAL. Journal of Molecular Neuroscience: Mn 28(3): 303-307
Devillard, L.; Vandroux, D.; Tissier, C.; Brochot, A.; Voisin, S.; Rochette, L.; Athias, P. 2006: Tubulin ligands suggest a microtubule-NADPH oxidase relationship in postischemic cardiomyocytes. European Journal of Pharmacology 548(1-3): 64-73
Fiore, G.; Di Cristo, C.; Monti, G.; Amoresano, A.; Columbano, L.; Pucci, P.; Cioffi, F.A.; Di Cosmo, A.; Palumbo, A.; d'Ischia, M. 2006: Tubulin nitration in human gliomas. Neuroscience Letters 394(1): 57-62
Yanagawa, T.; Noguchi, T.; Miyachi, H.; Kobayashi, H.; Hashimoto, Y. 2006: Tubulin polymerization inhibitors with a fluorinated phthalimide skeleton derived from thalidomide. Bioorganic and Medicinal Chemistry Letters 16(18): 4748-4751
Goebel, J.; Forrest, K.; Wills-Karp, M.; Roszman, T.L. 2006: Tubulin polymerization modulates interleukin-2 receptor signal transduction in human T cells. Journal of Receptor and Signal Transduction Research 26(1-2): 87-106
Aprea, S.; Del Valle, L.; Mameli, G.; Sawaya, B.E.; Khalili, K.; Peruzzi, F. 2006: Tubulin-mediated binding of human immunodeficiency virus-1 Tat to the cytoskeleton causes proteasomal-dependent degradation of microtubule-associated protein 2 and neuronal damage. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 26(15): 4054-4062
Inatsuki, S.; Noguchi, T.; Miyachi, H.; Oda, S.; Iguchi, T.; Kizaki, M.; Hashimoto, Y.; Kobayashi, H. 2005: Tubulin-polymerization inhibitors derived from thalidomide. Bioorganic and Medicinal Chemistry Letters 15(2): 321-325
Oakley, B.R. 2004: Tubulins in Aspergillus nidulans. Fungal Genetics and Biology: Fg and B 41(4): 420-427
Okoń, K. 2003: Tubulo-interstitial lesions in glomerulopathy. I. Pathogenesis. Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists 54(2): 87-94
Voghenzi, A.; Mattiuzzo, M.; De Rosa, E.; Stabellini, N. 2004: Tubulo-interstitial nephritis and uveitis syndrome associated with mastitis: a case report. Acta Paediatrica 93(1): 135-136
Hamdan, J.M.; Obeidat, F.N. 2006: Tubulo-interstitial nephritis and uveitis syndrome in a 6-year-old boy: case report. Annals of Tropical Paediatrics 26(2): 145-148
Lee, S.Eun.; Park, N.Hyun.; Park, I.Ae.; Kang, S.Beom.; Lee, H.Pyo. 2005: Tubulo-villous adenoma of the vagina. Gynecologic Oncology 96(2): 556-558
Denholm, B.; Skaer, H. 2003: Tubulogenesis: a role for the apical extracellular matrix?. Current Biology: Cb 13(23): R909-R911
Vallon, V. 2003: Tubuloglomerular feedback in the kidney: insights from gene-targeted mice. Pflugers Archiv: European Journal of Physiology 445(4): 470-476
Shi, Y.; Wang, X.; Chon, K.H.; Cupples, W.A. 2005: Tubuloglomerular feedback-dependent modulation of renal myogenic autoregulation by nitric oxide. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 290(4): R982-R991
Rodríguez-Iturbe, B.; Johnson, R.J.; Herrera-Acosta, J. 2005: Tubulointerstitial damage and progression of renal failure. Kidney International. Suppl 99: S82-S86
Danilewicz, M.; Wagrowska-Danilewicz, M. 2005: Tubulointerstitial expression of CD44 in acute rejection of human renal allografts. Periodicum Biologorum 107(2): 257-262
Tian, S.; Ding, G.; Jia, R.; Chu, G. 2006: Tubulointerstitial macrophage accumulation is regulated by sequentially expressed osteopontin and macrophage colony-stimulating factor: implication for the role of atorvastatin. Mediators of Inflammation 2: 12919
Liakopoulos, V.; Ioannidis, I.; Zengos, N.; Karabatsas, C.H.; Karasavvidou, F.; Salmas, M.; Kanelaki, E.; Eleftheriadis, T.; Stefanidis, I. 2006: Tubulointerstitial nephritis and uveitis (TINU) syndrome in a 52-year-old female: a case report and review of the literature. Renal Failure 28(4): 355-359
Howarth, L.; Gilbert, R.D.; Bass, P.; Deshpande, P.V. 2004: Tubulointerstitial nephritis and uveitis in monozygotic twin boys. Pediatric Nephrology 19(8): 917-919
Helms, E.; Servilla, K.S.; Hartshorne, M.F.; Harris, A.; Nichols, M.J.; Tzamaloukas, A.H. 2005: Tubulointerstitial nephritis and uveitis syndrome: use of gallium scintigraphy in its diagnosis and treatment. International Urology and Nephrology 37(1): 119-122
Wheeler, D.T.; Tai, L.H.; Bratthauer, G.L.; Waldner, D.L.; Tavassoli, F.A. 2004: Tubulolobular carcinoma of the breast: an analysis of 27 cases of a tumor with a hybrid morphology and immunoprofile. American Journal of Surgical Pathology 28(12): 1587-1593
Breton, G.; Alexandre, M.; Duval, X.; Prie, D.; Peytavin, G.; Leport, C.; Vildei, J-Louis. 2004: Tubulopathy consecutive to tenofovir-containing antiretroviral therapy in two patients infected with human immunodeficiency virus-1. Scandinavian Journal of Infectious Diseases 36(6-7): 527-528
Kaup, F-J.; Bruno, S.F.; Mätz-Rensing, K.; Schneider, T. 2005: Tubuloreticular structures in rectal biopsies of SIV-infected rhesus monkeys (Macaca mulatta). Ultrastructural Pathology 29(5): 357-366
Vitrey, D.; Frachon, S.; Balme, B.; Golfier, F. 2003: Tubulovillous adenoma of the vulva. Obstetrics and Gynecology 102(5 Pt 2): 1160-1163
Pavon, D. 2005: Tudorella sulcata sulcata (Draparnaud, 1805) (Gastropoda: Pomatudae) une espece patrimoniale de la malacofaune Francaise. Biocosme Mesogeen 21(4): 155-170
Urban, N.N.; Castro, J.B. 2005: Tuft calcium spikes in accessory olfactory bulb mitral cells. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 25(20): 5024-5028
Hishikawa, N.; Hashizume, Y.; Yoshida, M.; Niwa, J-Ichi.; Tanaka, F.; Sobue, G. 2005: Tuft-shaped astrocytes in Lewy body disease. Acta Neuropathologica 109(4): 373-380
Westergaard, G.C.; Liv, C.; Rocca, A.M.; Cleveland, A.; Suomi, S.J. 2004: Tufted capuchins (Cebus apella) attribute value to foods and tools during voluntary exchanges with humans. Animal Cognition 7(1): 19-24
Visalberghi, E.; Neel, C. 2003: Tufted capuchins (Cebus apella) use weight and sound to choose between full and empty nuts. Ecological Psychology 15(3): 215-228
Halsey, L.G.; Wallace, S.E.; Woakes, A.J.; Winkler, H.; Butler, P.J. 2005: Tufted ducks Aythya fuligula do not control buoyancy during diving. Journal of Avian Biology ; 36(3): 261-267
Slayton, R.L.; Cooper, M.E.; Marazita, M.L. 2005: Tuftelin, mutans streptococci, and dental caries susceptibility. Journal of Dental Research 84(8): 711-714
Wang, J.; Tsirka, S.E. 2005: Tuftsin fragment 1-3 is beneficial when delivered after the induction of intracerebral hemorrhage. Stroke 36(3): 613-618
Altug, T.; Turna, A.; Tefekli, A.; Turna, H.; Ozar, E.; Taskin, E.I.; Kaymaz, A.A.dogan 2005: Tuftsin protects against diabetes induced by multiple low-dose streptozotocin in mice. Indian Veterinary Journal 82(12): 1248-1251
Fridkin, M.; Tsubery, H.; Tzehoval, E.; Vonsover, A.; Biondi, L.; Filira, F.; Rocchi, R. 2005: Tuftsin-AZT conjugate: potential macrophage targeting for AIDS therapy. Journal of Peptide Science: An Official Publication of the European Peptide Society 11(1): 37-44
Y.rdakok, Murat 2004: Tuhfe-i Mubarizi'de cocuk hekimligi bilgileri. Cocuk Sagligi ve Hastaliklari Dergisi 47(3): 233-236
Kukkonen, S.K.J.; Vaheri, A.; Plyusnin, A. 2004: Tula hantavirus L protein is a 250 kDa perinuclear membrane-associated protein. Journal of General Virology 85(Part 5): 1181-1189
Li, X-Dong.; Kukkonen, S.; Vapalahti, O.; Plyusnin, A.; Lankinen, H.; Vaheri, A. 2004: Tula hantavirus infection of Vero E6 cells induces apoptosis involving caspase 8 activation. Journal of General Virology 85(Pt 11): 3261-3268
Li, X.-D.; Lankinen, H.; Putkuri, N.; Vapalahti, O.; Vaheri, A. 2005: Tula hantavirus triggers pro-apoptotic signals of ER stress in Vero E6 cells. Virology 333(1): 180-189
Tärnvik, A.; Priebe, H-Sabrina.; Grunow, R. 2004: Tularaemia in Europe: an epidemiological overview. Scandinavian Journal of Infectious Diseases 36(5): 350-355
Beckwith, C.S. 2006: Tularemia as a cause of fever in a squirrel monkey. Journal of the American Veterinary Medical Association 229(2): 269-273
Roberts, P. 2004: Tulasnella echinospora: an unusual new species from Great Britain and Sweden. Cryptogamie Mycologie 25(1): 23-27
Asai, I. 2004: Tulostoma striatum in Japan. Nippon Kingakukai Kaiho 45(1): 11-13
Zavortink, M.; Contreras, N.; Addy, T.; Bejsovec, A.; Saint, R. 2005: Tum/RacGAP50C provides a critical link between anaphase microtubules and the assembly of the contractile ring in Drosophila melanogaster. Journal of Cell Science 118(Part 22): 5381-5392
Guo, H.H.; Loeb, L.A. 2003: Tumbling down a different pathway to genetic instability. Journal of Clinical Investigation 112(12): 1793-1795
Hanigan, W.C.; Fraser, K.; Tarantino, M.; Wang, H. 2005: Tumefaction of the dural sinuses associated with a coagulopathy following treatment of hydrocephalus in a perinate: case report. Journal of Neurosurgery 102(4 Suppl): 426-430
Edmister, W.B.; Lane, J.I.; Gilbertson, J.R.; Brown, R.D.; Pollock, B.E. 2005: Tumefactive cysts: a delayed complication following radiosurgery for cerebral arterial venous malformations. Ajnr. American Journal of Neuroradiology 26(5): 1152-1157
Enzinger, C.; Strasser-Fuchs, S.; Ropele, S.; Kapeller, P.; Kleinert, R.; Fazekas, F. 2005: Tumefactive demyelinating lesions: conventional and advanced magnetic resonance imaging. Multiple Sclerosis 11(2): 135-139
Bussolin, L.; Busoni, P.; Giorgi, L.; Crescioli, M.; Messeri, A. 2003: Tumescent local anesthesia for the surgical treatment of burns and postburn sequelae in pediatric patients. Anesthesiology 99(6): 1371-1375
Boni, R. 2006: Tumescent power liposuction in the treatment of the enlarged male breast. Dermatology 213(2): 140-143
Jellouli, M.; Mekki, M.; Krichene, I.; Zakhama, A.; Belghith, M.; Jouini, R.; Sahnoun, L.; Rammeh, S.; Harbi, A.; Nouri, A. 2003: Tumeur desmoplastique a petites cellules rondes intra-abdominale de l'enfant: A propos d'une observation et revue de la litterature. Bulletin du Cancer (Montrouge) 90(12): 1063-1066
Debourdeau, P.; Gligorov, J.; Teixeira, L.; Aletti, M.; Zammit, C. 2004: Tumeurs cardiaques malignes. Bulletin du Cancer 91: S136-S146
Moussaid, L.; Benchikhi, H.; Boukind, E.H.; Sqalli, S.; Mouaki, N.; Kadiri, F.; Lakhdar, H. 2004: Tumeurs cutanees au cours du xeroderma pigmentosum au Maroc: Etude de 120 malades. Annales de Dermatologie et de Venereologie 131(1 Cahier 1): 29-33
Moujahid, M.; Daali, M.; Tajdine, M.T. 2005: Tumeurs malignes primitives du duodenum - A propos de cinq cas. Medecine et Armees 33(2): 187-192
Matoba, K.; Iizuka, N.; Gondo, T.; Ishihara, T.; Yamada-Okabe, H.; Tamesa, T.; Takemoto, N.; Hashimoto, K.; Sakamoto, K.; Miyamoto, T.; Uchimura, S.; Hamamoto, Y.; Oka, M. 2005: Tumor HLA-DR expression linked to early intrahepatic recurrence of hepatocellular carcinoma. International Journal of Cancer 115(2): 231-240
Orlova, A.; Magnusson, M.; Eriksson, T.L.J.; Nilsson, M.; Larsson, B.; Höidén-Guthenberg, I.; Widström, C.; Carlsson, Jörgen.; Tolmachev, V.; Ståhl, S.; Nilsson, F.Y. 2006: Tumor imaging using a picomolar affinity HER2 binding affibody molecule. Cancer Research 66(8): 4339-4348
Ventrucci, M.; Cipolla, A.; Racchini, C.; Casadei, R.; Simoni, P.; Gullo, L. 2004: Tumor M2-pyruvate kinase, a new metabolic marker for pancreatic cancer. Digestive Diseases and Sciences 49(7-8): 1149-1155
Mahoney, B.P.; Raghunand, N.; Baggett, B.; Gillies, R.J. 2003: Tumor acidity, ion trapping and chemotherapeutics. I. Acid pH affects the distribution of chemotherapeutic agents in vitro. Biochemical Pharmacology 66(7): 1207-1218
Raghunand, N.; Mahoney, B.P.; Gillies, R.J. 2003: Tumor acidity, ion trapping and chemotherapeutics. II. pH-dependent partition coefficients predict importance of ion trapping on pharmacokinetics of weakly basic chemotherapeutic agents. Biochemical Pharmacology 66(7): 1219-1229
Acquati, F.; Possati, L.; Ferrante, L.; Campomenosi, P.; Talevi, S.; Bardelli, S.; Margiotta, C.; Russo, A.; Bortoletto, E.; Rocchetti, R.; Calza, R.; Cinquetti, R.; Monti, L.; Salis, S.; Barbanti-Brodano, G.; Taramelli, R. 2005: Tumor and metastasis suppression by the human RNASET2 gene. International Journal of Oncology 26(5): 1159-1168
Vink, S.R.; Schellens, J.H.M.; van Blitterswijk, W.J.; Verheij, M. 2005: Tumor and normal tissue pharmacokinetics of perifosine, an oral anti-cancer alkylphospholipid. Investigational new Drugs 23(4): 279-286
Sajti, E.ö; Kavelaars, A.; van Meeteren, N.; Teunis, M.; Gispen, W.H.; Heijnen, C. 2004: Tumor angiogenesis and metastasis formation are associated with individual differences in behavior of inbred Lewis rats. Brain Behavior and Immunity 18(6): 497-504
Cao, Y. 2005: Tumor angiogenesis and therapy. Biomedicine and Pharmacotherapy 59(Suppl 2): S340-S343
Du, W.; Hattori, Y.; Hashiguchi, A.; Kondoh, K.; Hozumi, N.; Ikeda, Y.; Sakamoto, M.; Hata, J.-i.; Yamada, T. 2004: Tumor angiogenesis in the bone marrow of multiple myeloma patients and its alteration by thalidomide treatment. Pathology International 54(5): 285-294
Cuenod, C.A.; Fournier, L.; Balvay, D.; Guinebretière, J.-M. 2006: Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRi and CT assessment. Abdominal Imaging 31(2): 188-193
Amoura, Z.; Duhaut, P.; Huong, D.Le.Thi.; Wechsler, B.; Costedoat-Chalumeau, N.; Francès, C.; Cacoub, P.; Papo, T.; Cormont, S.; Touitou, Y.; Grenier, P.; Valeyre, D.; Piette, J-Charles. 2005: Tumor antigen markers for the detection of solid cancers in inflammatory myopathies. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 14(5): 1279-1282
Mufson, R.Allan 2006: Tumor antigen targets and tumor immunotherapy. Frontiers in Bioscience 11: 337-343
Knutson, K.L.; Disis, M.L. 2005: Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunology Immunotherapy: Cii 54(8): 721-728
Strasberg Rieber, M.; Anzellotti, A.; Sánchez-Delgado, R.A.; Rieber, M. 2004: Tumor apoptosis induced by ruthenium(II)-ketoconazole is enhanced in nonsusceptible carcinoma by monoclonal antibody to EGF receptor. International Journal of Cancer 112(3): 376-384
Mani, K.; Belting, M.; Ellervik, U.; Falk, N.; Svensson, G.; Sandgren, S.; Cheng, F.; Fransson, L-Ake. 2004: Tumor attenuation by 2(6-hydroxynaphthyl)-beta-D-xylopyranoside requires priming of heparan sulfate and nuclear targeting of the products. Glycobiology 14(5): 387-397
Cai, X-song.; Jia, Y-wei.; Mei, J.; Tang, R-yong. 2004: Tumor blood vessels formation in osteosarcoma: vasculogenesis mimicry. Chinese Medical Journal 117(1): 94-98
Inagaki, T.; Bhayani, S.B.; Allaf, M.E.; Ong, A.M.; Rha, K.H.; Petresior, D.; Patriciu, A.; Varkarakis, I.M.; Jarrett, T.W.; Stoianovici, D.; Kavoussi, L.R. 2004: Tumor capacitance: electrical measurements of renal neoplasia. Journal of Urology 172(2): 454-457
Onn, A.; Choe, D.Hwan.; Herbst, R.S.; Correa, A.M.; Munden, R.F.; Truong, M.T.; Vaporciyan, A.A.; Isobe, T.; Gilcrease, M.Z.; Marom, E.M. 2005: Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome. Radiology 237(1): 342-347
Wang, H.; Fu, W.; Im, J.Hong.; Zhou, Z.; Santoro, S.A.; Iyer, V.; DiPersio, C.Mike.; Yu, Q-Chun.; Quaranta, V.; Al-Mehdi, A.; Muschel, R.J. 2004: Tumor cell alpha3beta1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis. Journal of Cell Biology 164(6): 935-941
Yigitbasi, O.G.; Younes, M.N.; Doan, D.; Jasser, S.A.; Schiff, B.A.; Bucana, C.D.; Bekele, B.N.; Fidler, I.J.; Myers, J.N. 2004: Tumor cell and endothelial cell therapy of oral cancer by dual tyrosine kinase receptor blockade. Cancer Research 64(21): 7977-7984
Schoppmeyer, K.; Frühauf, N.; Oldhafer, K.; Seeber, S.; Kasimir-Bauer, S. 2006: Tumor cell dissemination in colon cancer does not predict extrahepatic recurrence in patients undergoing surgery for hepatic metastases. Oncology Reports 15(2): 449-454
Chibana, Y.; Fujii, S.; Ichikawa, K.; Fujita, M.; Ono, Y.; Tomita, S.; Imura, J.; Kawamata, H.; Terano, A.; Fujimori, T. 2005: Tumor cell dissociation score highly correlates with lymph node metastasis in superficial esophageal carcinoma. Journal of Gastroenterology and Hepatology 20(9): 1371-1378
Oldford, S.A.; Robb, J.Desmond.; Codner, D.; Gadag, V.; Watson, P.H.; Drover, S. 2006: Tumor cell expression of HLA-DM associates with a Th1 profile and predicts improved survival in breast carcinoma patients. International Immunology 18(11): 1591-1602
Gogichadze, G.K.; Misabishvili, E.V.; Gogichadze, T.G. 2006: Tumor cell formation by normal somatic cells fusing and cancer prevention prospects. Medical Hypotheses 66(1): 133-136
Heink, S.; Fricke, B.; Ludwig, D.; Kloetzel, P.-M.; Krüger, E. 2006: Tumor cell lines expressing the proteasome subunit isoform LMP7E1 exhibit immunoproteasome deficiency. Cancer Research 66(2): 649-652
Casas, A.; Perotti, C.; Ortel, B.; Di Venosa, G.; Saccoliti, Mía.; Batlle, A.; Hasan, T. 2006: Tumor cell lines resistant to ALA-mediated photodynamic therapy and possible tools to target surviving cells. International Journal of Oncology 29(2): 397-405
Hokey, D.A.; Larregina, A.T.; Erdos, G.; Watkins, S.C.; Falo, L.D. 2005: Tumor cell loaded type-1 polarized dendritic cells induce Th1-mediated tumor immunity. Cancer Research 65(21): 10059-10067
Niggemann, B.; Drell, T.L.; Joseph, J.; Weidt, C.; Lang, K.; Zaenker, K.S.; Entschladen, F. 2004: Tumor cell locomotion: differential dynamics of spontaneous and induced migration in a 3D collagen matrix. Experimental Cell Research 298(1): 178-187
Rowe, L.R.; Willmore-Payne, C.; Tripp, S.R.; Perkins, S.L.; Bentz, J.S. 2006: Tumor cell nuclei extraction from paraffin-embedded lymphoid tissue for fluorescence in situ hybridization. Applied Immunohistochemistry and Molecular Morphology: Aimm 14(2): 220-224
Van der Schaft, D.W.J.; Hillen, F.; Pauwels, P.; Kirschmann, D.A.; Castermans, K.; Egbrink, M.G.A.O.; Tran, M.G.B.; Sciot, R.; Hauben, E.; Hogendoorn, P.C.W.; Delattre, O.; Maxwell, P.H.; Hendrix, M.J.C.; Griffioen, A.W. 2005: Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia. Cancer Research 65(24): 11520-11528
Folberg, R.; Arbieva, Z.; Moses, J.; Hayee, A.; Sandal, T.; Kadkol, S.; Lin, A.Y.; Valyi-Nagy, K.; Setty, S.; Leach, L.; Chévez-Barrios, P.; Larsen, P.; Majumdar, D.; Pe'er, J.; Maniotis, A.J. 2006: Tumor cell plasticity in uveal melanoma: microenvironment directed dampening of the invasive and metastatic genotype and phenotype accompanies the generation of vasculogenic mimicry patterns. American Journal of Pathology 169(4): 1376-1389
Dionigi, P.; Ferrari, A.; Jemos, V.; Luinetti, O.; Vai, L.; Guizzetti, M.; Ferrari, C.; Jemos, K.; Spada, M.; Mazzini, G. 2004: Tumor cell proliferation in early gastric cancer: biological and clinical behavior. Hepato-Gastroenterology 51(55): 264-268
Gerweck, L.E.; Vijayappa, S.; Kurimasa, A.; Ogawa, K.; Chen, D.J. 2006: Tumor cell radiosensitivity is a major determinant of tumor response to radiation. Cancer Research 66(17): 8352-8355
Findlay, V.J.; Townsend, D.M.; Saavedra, J.E.; Buzard, G.S.; Citro, M.L.; Keefer, L.K.; Ji, X.; Tew, K.D. 2004: Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrug. Molecular Pharmacology 65(5): 1070-1079
DeFeo-Jones, D.; Barnett, S.F.; Fu, S.; Hancock, P.J.; Haskell, K.M.; Leander, K.R.; McAvoy, E.; Robinson, R.G.; Duggan, M.E.; Lindsley, C.W.; Zhao, Z.; Huber, H.E.; Jones, R.E. 2005: Tumor cell sensitization to apoptotic stimuli by selective inhibition of specific Akt/PKB family members. Molecular Cancer Therapeutics 4(2): 271-279
Riddle, D.S.; Sanz, L.; Chong, H.; Thompson, J.; Vile, R.G. 2005: Tumor cell surface display of immunoglobulin heavy chain Fc by gene transfer as a means to mimic antibody therapy. Human Gene Therapy 16(7): 830-844
Sabeh, F.; Ota, I.; Holmbeck, K.; Birkedal-Hansen, H.; Soloway, P.; Balbin, M.; Lopez-Otin, C.; Shapiro, S.; Inada, M.; Krane, S.; Allen, E.; Chung, D.; Weiss, S.J. 2004: Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. Journal of Cell Biology 167(4): 769-781
Sirchia, R.; Ciacciofera, V.; Luparello, C. 2003: Tumor cell-collagen interactions: Identification and semi-quantitative evaluation of selectively-expressed genes by combination of differential display- and multiplex-PCR. Biological Procedures Online 5: 222-227
Vasiljeva, O.; Papazoglou, A.; Krüger, A.; Brodoefel, H.; Korovin, M.; Deussing, J.; Augustin, N.; Nielsen, B.S.; Almholt, K.; Bogyo, M.; Peters, C.; Reinheckel, T. 2006: Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. Cancer Research 66(10): 5242-5250
Hu, D-En.; Dyke, S.O.M.; Moore, A.M.; Thomsen, L.L.; Brindle, K.M. 2004: Tumor cell-derived nitric oxide is involved in the immune-rejection of an immunogenic murine lymphoma. Cancer Research 64(1): 152-161
Mytar, B.; Wołoszyn, M.; Szatanek, R.ł; Baj-Krzyworzeka, M.; Siedlar, M.; Ruggiero, I.; Wieckiewicz, J.; Zembala, M. 2003: Tumor cell-induced deactivation of human monocytes. Journal of Leukocyte Biology 74(6): 1094-1101
Ibanez de Caceres, I.; Battagli, C.; Esteller, M.; Herman, J.G.; Dulaimi, E.; Edelson, M.I.; Bergman, C.; Ehya, H.; Eisenberg, B.L.; Cairns, P. 2004: Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients. Cancer Research 64(18): 6476-6481
Noguchi, K.; Kuwada, E.; Goto, S.; Egawa, K. 2004: Tumor cell-specific transcription of a murine histocompatibility class Ib Q5 gene. Anticancer Research 24(5c): 3379-3386
Yaniv, I.; Cohen, I.J.; Stein, J.; Zilberstein, J.; Liberzon, E.; Atlas, O.; Grunshpan, A.; Sverdlov, Y.; Ash, S.; Zaizov, R.; Avigad, S. 2004: Tumor cells are present in stem cell harvests of Ewings sarcoma patients and their persistence following transplantation is associated with relapse. Pediatric Blood and Cancer 42(5): 404-409
Ghiringhelli, Fçois.; Puig, P.E.; Roux, S.; Parcellier, A.; Schmitt, E.; Solary, E.; Kroemer, G.; Martin, Fçois.; Chauffert, B.; Zitvogel, L. 2005: Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation. Journal of Experimental Medicine 202(7): 919-929
del Fresno, C.; Otero, K.; Gómez-García, L.; González-León, M.Carmen.; Soler-Ranger, L.; Fuentes-Prior, P.; Escoll, P.; Baos, R.; Caveda, L.; García, F.; Arnalich, F.; López-Collazo, E. 2005: Tumor cells deactivate human monocytes by up-regulating IL-1 receptor associated kinase-M expression via CD44 and TLR4. Journal of Immunology 174(5): 3032-3040
Frank, O.; Rudolph, C.; Heberlein, C.; von Neuhoff, N.; Schröck, E.; Schambach, A.; Schlegelberger, B.; Fehse, B.; Ostertag, W.; Stocking, C.; Baum, C. 2004: Tumor cells escape suicide gene therapy by genetic and epigenetic instability. Blood 104(12): 3543-3549
Pascale, E.; Cimino Reale, G.; D'Ambrosio, E. 2004: Tumor cells fail to trans-induce telomerase in human umbilical vein endothelial cell cultures. Cancer Research 64(21): 7702-7705
Jiang, P.; Yamauchi, K.; Yang, M.; Tsuji, K.; Xu, M.; Maitra, A.; Bouvet, M.; Hoffman, R.M. 2006: Tumor cells genetically labeled with GFP in the nucleus and RFP in the cytoplasm for imaging cellular dynamics. Cell Cycle 5(11): 1198-1201
Poruchynsky, M.S.; Kim, J-Hyeok.; Nogales, E.; Annable, T.; Loganzo, F.; Greenberger, L.M.; Sackett, D.L.; Fojo, T. 2004: Tumor cells resistant to a microtubule-depolymerizing hemiasterlin analogue, HTI-286, have mutations in alpha- or beta-tubulin and increased microtubule stability. Biochemistry 43(44): 13944-13954
Ma, H-Ling.; Whitters, M.J.; Jacobson, B.A.; Donaldson, D.D.; Collins, M.; Dunussi-Joannopoulos, K. 2004: Tumor cells secreting IL-13 but not IL-13Ralpha2 fusion protein have reduced tumorigenicity in vivo. International Immunology 16(7): 1009-1017
Thompson, J.A.; Dissanayake, S.K.; Ksander, B.R.; Knutson, K.L.; Disis, M.L.; Ostrand-Rosenberg, S. 2006: Tumor cells transduced with the MHC class Ii Transactivator and CD80 activate tumor-specific CD4+ T cells whether or not they are silenced for invariant chain. Cancer Research 66(2): 1147-1154
Si, S.-Y.; Hu, P.-Z.; Huang, Y.-Y.; Ye, J.; Huang, Y.; Li, Z.-S.; Ge, W.; Li, X.; Qu, P.; Zhang, X.-M.; Sui, Y.-F. 2006: Tumor cells with B7.1 and transmembrane anchored staphylococcal enterotoxin a generate effective antitumor immunity. Biochemical and Biophysical Research Communications 347(1): 208-214
Nagaoka, Y.; Kumagai, A.; Tokuda, H.; Nishino, H.; Hara, Y.; Uesato, S. 2005: Tumor chemopreventive effect of orally administered (-)-epigallocatechin and its 3-O-acylated derivatives on the two stage mouse skin carcinogenesis induced by peroxynitrite and 12-O-tetradecanoylphorbol-13-acetate. Natural Medicines 59(1): 49-51
Wang, J.; Bø, T.Hellem.; Jonassen, I.; Myklebost, O.; Hovig, E. 2003: Tumor classification and marker gene prediction by feature selection and fuzzy c-means clustering using microarray data. Bmc Bioinformatics 4: 60
Wang, Y.; Makedon, F.; Pearlman, J. 2006: Tumor classification based on DNA copy number aberrations determined using SNP arrays. Oncology Reports 15(4): 1057-1059
Desper, R.; Khan, J.; Schäffer, A.A. 2004: Tumor classification using phylogenetic methods on expression data. Journal of Theoretical Biology 228(4): 477-496
Copp, H.; Bissonette, E.A.; Theodorescu, D. 2005: Tumor control outcomes of patients treated with trimodality therapy for locally advanced prostate cancer. Urology 65(6): 1146-1151
Chen, Y.; Geng, J.; Tian, J.; He, Y.; Chen, S. 2004: Tumor control probability for tumor therapy with beta radionuclide interstitial injection. Bio-Medical Materials and Engineering 14(3): 333-335
Igney, F.H.; Krammer, P.H. 2005: Tumor counterattack: fact or fiction?. Cancer Immunology Immunotherapy: Cii 54(11): 1127-1136
Iwamoto, A.; Ikeguchi, M.; Matsumoto, S.; Hukumoto, Y.; Inoue, M.; Ozaki, T.; Ataka, M.; Tanida, T.; Endo, K.; Katano, K.; Hirooka, Y. 2006: Tumor cyclooxygenase-2 gene suppresses local immune responses in patients with hepatocellular carcinoma. Tumori 92(2): 130-133
Simaga, S.; Babić, D.; Osmak, M.; Sprem, M.; Abramić, M. 2003: Tumor cytosol dipeptidyl peptidase III activity is increased with histological aggressiveness of ovarian primary carcinomas. Gynecologic Oncology 91(1): 194-200
Soares, B.S.; Eguchi, K.; Frohman, L.A. 2005: Tumor deletion mapping on chromosome 11q13 in eight families with isolated familial somatotropinoma and in 15 sporadic somatotropinomas. Journal of Clinical Endocrinology and Metabolism 90(12): 6580-6587
Cabrera-Morales, C.M. 2005: Tumor desmoplasico de celulas pequenas y redondas (DSRCT) de rinon. Oncologia 28(5): 38-42
Carboni, J.M.; Lee, A.V.; Hadsell, D.L.; Rowley, B.R.; Lee, F.Y.; Bol, D.K.; Camuso, A.E.; Gottardis, M.; Greer, A.F.; Ho, C.P.; Hurlburt, W.; Li, A.; Saulnier, M.; Velaparthi, U.; Wang, C.; Wen, M.-L.; Westhouse, R.A.; Wittman, M.; Zimmermann, K.; Rupnow, B.A.; Wong, T.W. 2005: Tumor development by transgenic expression of a constitutively active insulin-like growth factor i receptor. Cancer Research 65(9): 3781-3787
Smilenov, L.B. 2006: Tumor development: haploinsufficiency and local network assembly. Cancer Letters 240(1): 17-28
Tsuji, T.; Sawai, T.; Takeshita, H.; Nakagoe, T.; Hidaka, S.; Yamaguchi, H.; Yasutake, T.; Nagayasu, T.; Tagawa, Y. 2004: Tumor dihydropyrimidine dehydrogenase expression is a useful marker in adjuvant therapy with oral fluoropyrimidines after curative resection of colorectal cancer. Cancer ChemoTherapy and Pharmacology 54(6): 531-536
Tsuji, T.; Sawai, T.; Takeshita, H.; Nakagoe, T.; Hidaka, S.; Atsushi Nanashima; Yamaguchi, H.; Yasutake, T.; Nagayasu, T.; Tagawa, Y. 2004: Tumor dihydropyrimidine dehydrogenase in stage Ii and IIi colorectal cancer: low level expression is a beneficial marker in oral-adjuvant chemotherapy, but is also a predictor for poor prognosis in patients treated with curative surgery alone. Cancer Letters 204(1): 97-104
Felsher, D.W. 2006: Tumor dormancy: death and resurrection of cancer as seen through transgenic mouse models. Cell Cycle 5(16): 1808-1811
Shachaf, C.M.; Felsher, D.W. 2005: Tumor dormancy and MYC inactivation: pushing cancer to the brink of normalcy. Cancer Research 65(11): 4471-4474
Ozono, S.; Miyao, N.; Igarashi, T.; Marumo, K.; Nakazawa, H.; Fukuda, M.; Tsushima, T.; Tokuda, N.; Kawamura, J.; Murai, M. 2004: Tumor doubling time of renal cell carcinoma measured by CT: collaboration of Japanese Society of Renal Cancer. Japanese Journal of Clinical Oncology 34(2): 82-85
Morsey, H.; Aslam, M.; Standfield, N. 2004: Tumor embolization causing acute ischemia with sometimes fatal results. Case report and review of literature. International Angiology: a Journal of the International Union of Angiology 23(1): 82-84
Dutour, A.; Rigaud, M. 2005: Tumor endothelial cells are targets for selective therapies: in vitro and in vivo models to evaluate antiangiogenic strategies. Anticancer Research 25(6b): 3799-3807
Amin, D.N.; Hida, K.; Bielenberg, D.R.; Klagsbrun, M. 2006: Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors. Cancer Research 66(4): 2173-2180
Nanda, A.; Karim, B.; Peng, Z.; Liu, G.; Qiu, W.; Gan, C.; Vogelstein, B.; St Croix, B.; Kinzler, K.W.; Huso, D.L. 2006: Tumor endothelial marker 1 (Tem1) functions in the growth and progression of abdominal tumors. Proceedings of the National Academy of Sciences of the United States of America 103(9): 3351-3356
Chen, P.W.; Uno, T.; Ksander, B.R. 2006: Tumor escape mutants develop within an immune-privileged environment in the absence of T cell selection. Journal of Immunology 177(1): 162-168
Abusamra, A.J.; Zhong, Z.; Zheng, X.; Li, M.; Ichim, T.E.; Chin, J.L.; Min, W.-P. 2005: Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis. Blood Cells Molecules and Diseases 35(2): 169-173
Platt, K., L.; Dienes, H., P.; Tommasone, M.; Luch, A. 2004: Tumor formation in the neonatal mouse bioassay indicates that the potent carcinogen dibenzo(def,p)chrysene (dibenzo(a,l)pyrene) is activated in vivo via its trans- 11, 12-dihydrodiol. Chemico Biological Interactions 148(1-2): 27-36
Hata, K.; Yamada, Y.; Kuno, T.; Hirose, Y.; Hara, A.; Qiang, S.Hong.; Mori, H. 2004: Tumor formation is correlated with expression of beta-catenin-accumulated crypts in azoxymethane-induced colon carcinogenesis in mice. Cancer Science 95(4): 316-320
Mazumdar, M.; Lee, J.-H.; Sengupta, K.; Ried, T.; Rane, S.; Misteli, T. 2006: Tumor formation via loss of a molecular motor protein. Current Biology: Cb 16(15): 1559-1564
Lahm, H.; André, S.; Hoeflich, A.; Kaltner, H.; Siebert, H.-C.; Sordat, B.; von der Lieth, C.-W.; Wolf, E.; Gabius, H.-J. 2004: Tumor galectinology: insights into the complex network of a family of endogenous lectins. Glycoconjugate Journal 20(4): 227-238
Varga, A.; Czifra, G.; Tállai, B.él.; Németh, T.ás.; Kovács, I.; Kovács, L.ás.ó; Bíró, T.ás. 2004: Tumor grade-dependent alterations in the protein kinase C isoform pattern in urinary bladder carcinomas. European Urology 46(4): 462-465
Lee, E.H.; Ding, W.; Kulkarni, A.D.; Granstein, R.D.; Kulkarni, A.D. 2005: Tumor growth and immune function in mice during hind-limb unloading. Aviation Space and Environmental Medicine 76(6): 536-540
Richards, J.O.; Chang, X.; Blaser, B.W.; Caligiuri, M.A.; Zheng, P.; Liu, Y. 2006: Tumor growth impedes natural-killer-cell maturation in the bone marrow. Blood 108(1): 246-252
Quidville, V.; Segond, N.; Pidoux, E.; Cohen, R.; Jullienne, A.; Lausson, S. 2004: Tumor growth inhibition by indomethacin in a mouse model of human medullary thyroid cancer: implication of cyclooxygenases and 15-hydroxyprostaglandin dehydrogenase. Endocrinology 145(5): 2561-2571
Tsuzuki, T.; Tokuyama, Y.; Igarashi, M.; Miyazawa, T. 2004: Tumor growth suppression by alpha-eleostearic acid, a linolenic acid isomer with a conjugated triene system, via lipid peroxidation. Carcinogenesis 25(8): 1417-1425
Maruyama, Y.; Ono, M.; Kawahara, A.; Yokoyama, T.; Basaki, Y.; Kage, M.; Aoyagi, S.; Kinoshita, H.; Kuwano, M. 2006: Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. Cancer Research 66(12): 6233-6242
Mueller, L.; Goettsche, J.; Abdulgawad, A.; Vashist, Y.K.; Meyer, J.; Wilms, C.; Hillert, C.; Rogiers, X.; Broering, D.C. 2005: Tumor growth-promoting cellular host response during liver atrophy after portal occlusion. Liver International: Official Journal of the International Association for the Study of the Liver 25(5): 994-1001
O'Sullivan, M.; Budhraja, V.; Sadovsky, Y.; Pfeifer, J.D. 2005: Tumor heterogeneity affects the precision of microarray analysis. Diagnostic Molecular Pathology: the American Journal of Surgical Pathology Part B 14(2): 65-71
Korkolis, D.P.; Tsoli, E.; Fouskakis, D.; Yiotis, J.; Koullias, G.J.; Giannopoulos, D.; Papalambros, E.; Nikiteas, N.I.; Spiliopoulou, C.A.; Patsouris, E.; Asimacopoulos, P.; Gorgoulis, V.G. 2004: Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer patients. Anticancer Research 24(3b): 2061-2068
Zhou, J.; Schmid, T.; Schnitzer, S.; Brüne, B. 2006: Tumor hypoxia and cancer progression. Cancer Letters 237(1): 10-21
Büchler, P.; Reber, H.A.; Lavey, R.S.; Tomlinson, J.; Büchler, M.W.; Friess, H.; Hines, O.J. 2004: Tumor hypoxia correlates with metastatic tumor growth of pancreatic cancer in an orthotopic murine model. Journal of Surgical Research 120(2): 295-303
Nordsmark, M.; Overgaard, J. 2004: Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer. Acta Oncologica 43(4): 396-403
Kizaka-Kondoh, S.; Inoue, M.; Harada, H.; Hiraoka, M. 2003: Tumor hypoxia: a target for selective cancer therapy. Cancer Science 94(12): 1021-1028
Ekmekcioglu, S.; Ellerhorst, J.A.; Prieto, V.G.; Johnson, M.M.; Broemeling, L.D.; Grimm, E.A. 2006: Tumor iNOS predicts poor survival for stage IIi melanoma patients. International Journal of Cancer 119(4): 861-866
Jiang, T.; Olson, E.S.; Nguyen, Q.T.; Roy, M.; Jennings, P.A.; Tsien, R.Y. 2004: Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proceedings of the National Academy of Sciences of the United States of America 101(51): 17867-17872
Blankenberg, F.G.; Mandl, S.; Cao, Y-An.; O'Connell-Rodwell, C.; Contag, C.; Mari, C.; Gaynutdinov, T.I.; Vanderheyden, J-Luc.; Backer, M.V.; Backer, J.M. 2004: Tumor imaging using a standardized radiolabeled adapter protein docked to vascular endothelial growth factor. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 45(8): 1373-1380
van Waarde, A.; Buursma, A.Rixt.; Hospers, G.A.P.; Kawamura, K.; Kobayashi, T.; Ishii, K.; Oda, K.; Ishiwata, K.; Vaalburg, W.; Elsinga, P.H. 2004: Tumor imaging with 2 sigma-receptor ligands, 18F-FE-SA5845 and 11C-SA4503: a feasibility study. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 45(11): 1939-1945
Lang, K.; Entschladen, F.; Weidt, C.; Zaenker, K.S. 2006: Tumor immune escape mechanisms: impact of the neuroendocrine system. Cancer Immunology Immunotherapy: Cii 55(7): 749-760
Kannagi, M.; Harashima, N.; Kurihara, K.; Ohashi, T.; Utsunomiya, A.; Tanosaki, R.; Masuda, M.; Tomonaga, M.; Okamura, J. 2005: Tumor immunity against adult T-cell leukemia. Cancer Science 96(5): 249-255
Myers, A.L.; Krewet, J.A.; Shah, M.R. 2005: Tumor immunity and prolonged survival following combined adenovirus-HSP72 and CEA-plasmid vaccination. Vaccine 23(27): 3565-3571
Sinha, P.; Clements, V.K.; Miller, S.; Ostrand-Rosenberg, S. 2005: Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression. Cancer Immunology Immunotherapy: Cii 54(11): 1137-1142
Khan-Farooqi, H.R.; Prins, R.M.; Liau, L.M. 2005: Tumor immunology, immunomics and targeted immunotherapy for central nervous system malignancies. Neurological Research 27(7): 692-702
Lu, X.; Kallinteris, N.L.; Li, J.; Wu, S.; Li, Y.; Jiang, Z.; Hillman, G.G.; Gulfo, J.V.; Humphreys, R.E.; Xu, M. 2003: Tumor immunotherapy by converting tumor cells to MHC class II-positive, Ii protein-negative phenotype. Cancer Immunology Immunotherapy: Cii 52(10): 592-598
Lee, J.; Fassnacht, M.; Nair, S.; Boczkowski, D.; Gilboa, E. 2005: Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts. Cancer Research 65(23): 11156-11163
Graddis, T.J.; Diegel, M.L.; McMahan, C.J.; Tsavler, L.; Laus, R.; Vidovic, D. 2004: Tumor immunotherapy with alternative reading frame peptide antigens. Immunobiology 209(7): 535-544
Longerich, T.; Ketterer, K.; Helmke, B.M.; Friess, H.; Schirmacher, P. 2005: Tumor induced local fibrogenic effect by hepatic metastasis of insulinoma. Virchows Archiv: An International Journal of Pathology 446(6): 680-681
Rennefahrt, U.; Illert, B.; Greiner, A.; Rapp, U.R.; Troppmair, J. 2004: Tumor induction by activated JNK occurs through deregulation of cellular growth. Cancer Letters 215(1): 113-124
Ando, K.; Koike, S.; Oohira, C.; Ogiu, T.; Yatagai, F. 2005: Tumor induction in mice locally irradiated with carbon ions: a retrospective analysis. Journal of Radiation Research 46(2): 185-190
Hadrup, S.R.; Braendstrup, O.; Jacobsen, G.K.; Mortensen, S.; Pedersen, L.Øs.; Seremet, T.; Andersen, M.H.; Becker, J.ür.C.; Straten, P.T. 2006: Tumor infiltrating lymphocytes in seminoma lesions comprise clonally expanded cytotoxic T cells. International Journal of Cancer 119(4): 831-838
Staibano, S.; Mascolo, M.; Tranfa, F.; Salvatore, G.; Mignogna, C.; Bufo, P.; Nugnes, L.; Bonavolontà, G.; De Rosa, G. 2006: Tumor infiltrating lymphocytes in uveal melanoma: a link with clinical behavior?. International Journal of Immunopathology and Pharmacology 19(1): 171-179
Zhang, L.; Mandel, C.; Yang, Z-yan.; Yang, Q.; Nibbs, R.; Westerman, D.; Pitman, A. 2006: Tumor infiltration of bone marrow in patients with hemato-logical malignancies: dynamic contrast-enhanced magnetic resonance imaging. Chinese Medical Journal 119(15): 1256-1262
Albini, A.; Tosetti, F.; Benelli, R.; Noonan, D.M. 2005: Tumor inflammatory angiogenesis and its chemoprevention. Cancer Research 65(23): 10637-10641
Liu, S.; Luo, X.; Li, D.; Zhang, J.; Qiu, D.; Liu, W.; She, L.; Yang, Z. 2006: Tumor inhibition and improved immunity in mice treated with flavone from Cirsium japonicum DC. International Immunopharmacology 6(9): 1387-1393
Kappel, S.; Matthess, Y.; Zimmer, B.; Kaufmann, M.; Strebhardt, K. 2006: Tumor inhibition by genomically integrated inducible RNAi-cassettes. Nucleic Acids Research 34(16): 4527-4536
Chen-Zhen; Guo-Qing-Long; Gao-Xiang-Dong; Qian-Zhi-Yu 2005: Tumor inhibitory effect of YCP (a marine fugal polysaccharide) (I). Chinese Journal of Natural Medicines 3(6): 396-400
Wicki, A.; Lehembre, Fçois.; Wick, N.; Hantusch, B.; Kerjaschki, D.; Christofori, G. 2006: Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 9(4): 261-272
Naya, Y.; Slaton, J.W.; Troncoso, P.; Okihara, K.; Babaian, R.J. 2004: Tumor length and location of cancer on biopsy predict for side specific extraprostatic cancer extension. Journal of Urology 171(3): 1093-1097
Larson, S.M.; Morris, M.; Gunther, I.; Beattie, B.; Humm, J.L.; Akhurst, T.A.; Finn, R.D.; Erdi, Y.; Pentlow, K.; Dyke, J.; Squire, O.; Bornmann, W.; McCarthy, T.; Welch, M.; Scher, H. 2004: Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 45(3): 366-373
Franchi, A.; Gallo, O.; Massi, D.; Baroni, G.; Santucci, M. 2004: Tumor lymphangiogenesis in head and neck squamous cell carcinoma: a morphometric study with clinical correlations. Cancer 101(5): 973-978
Miyata, Y.; Kanda, S.; Ohba, K.; Nomata, K.; Eguchi, J.; Hayashida, Y.; Kanetake, H. 2006: Tumor lymphangiogenesis in transitional cell carcinoma of the upper urinary tract: association with clinicopathological features and prognosis. Journal of Urology 176(1): 348-353
Jaskiewicz, A.D.; Herrington, J.D.; Wong, L. 2005: Tumor lysis syndrome after bortezomib therapy for plasma cell leukemia. PharmacoTherapy 25(12): 1820-1825
Sorscher, S.M. 2004: Tumor lysis syndrome following docetaxel therapy for extensive metastatic prostate cancer. Cancer ChemoTherapy and Pharmacology 54(2): 191-192
Alavi, S.; Arzanian, M.Taghi.; Abbasian, M.Reza.; Ashena, Z. 2006: Tumor lysis syndrome in children with non-Hodgkin lymphoma. Pediatric Hematology and Oncology 23(1): 65-70
Kobayashi, T.; Yamanaka, R.; Homma, J.; Tsuchiya, N.; Yajima, N.; Yoshida, S.; Tanaka, R. 2003: Tumor mRNA-loaded dendritic cells elicit tumor-specific CD8(+) cytotoxic T cells in patients with malignant glioma. Cancer Immunology Immunotherapy: Cii 52(10): 632-637
Espey, M.G. 2006: Tumor macrophage redox and effector mechanisms associated with hypoxia. Free Radical Biology and Medicine 41(11): 1621-1628
Sugio, K.; Sugaya, M.; Hanagiri, T.; Yasumoto, K. 2004: Tumor marker in primary lung cancer. Journal of Uoeh 26(4): 473-479
Akimaru, K.; Yokomuro, S.; Aimoto, T.; Yoshida, H.; Uchida, E.; Tajiri, T. 2004: Tumor marker measurements of cells in a fine needle used for aspiration cytology. Analytical and Quantitative Cytology and Histology 26(5): 249-254
Rye, P.D.; Nustad, K.; Stigbrand, T. 2003: Tumor marker workshops. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 24(4): 165-171
Miyata, T.; Jige, M.; Nakaminami, T.; Uragami, T. 2006: Tumor marker-responsive behavior of gels prepared by biomolecular imprinting. Proceedings of the National Academy of Sciences of the United States of America 103(5): 1190-1193
Molina, R.; Filella, X.; Augé, J.M.; Fuentes, R.; Bover, I.; Rifa, J.; Moreno, V.; Canals, E.; Viñolas, N.; Marquez, A.; Barreiro, E.; Borras, J.; Viladiu, P. 2003: Tumor markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis. Comparison with the main clinical and pathological prognostic factors. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 24(4): 209-218
Briese, V.; Szabo, D.G.; Than, G.N.; Willroth, P.O.; Brieses, J. 2005: Tumor markers (pregnancy protein 1, placental-specific tissue protein 10, placental-specific tissue protein 12, alpha1-fetoprotein) in patients with bronchial carcinoma. Anticancer Research 25(3a): 1667-1670
Büntzel, J.; Hornig, A.; Glatzel, M.; Micke, O.; Bruns, F.; Schäfer, U.; Fröhlich, D. 2005: Tumor markers and lymphatic metastasis in head and neck cancer patients. Anticancer Research 25(3a): 1539-1542
Trapé, J.; Buxo, J.; Pérez de Olaguer, J.; Vidal, C. 2003: Tumor markers as prognostic factors in treated non-small cell lung cancer. Anticancer Research 23(5b): 4277-4281
Molina, R.; Barak, V.; van Dalen, A.; Duffy, M.J.; Einarsson, R.; Gion, M.; Goike, H.; Lamerz, R.; Nap, M.; Sölétormos, Görgy.; Stieber, P. 2005: Tumor markers in breast cancer- European Group on Tumor Markers recommendations. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 26(6): 281-293
Agnantis, N.J.; Goussia, A.C.; Batistatou, A.; Stefanou, D. 2004: Tumor markers in cancer patients. an update of their prognostic significance. Part II. In Vivo 18(4): 481-488
Dasgupta, S.; Bhattacharya-Chatterjee, M.; O'Malley, B.W.; Chatterjee, S.K. 2005: Tumor metastasis in an orthotopic murine model of head and neck cancer: possible role of TGF-beta 1 secreted by the tumor cells. Journal of Cellular Biochemistry 97(5): 1036-1051
Sánchez-Aguilera, A.; Montalbán, C.; de la Cueva, P.; Sánchez-Verde, L.; Morente, M.M.; García-Cosío, Mónica.; García-Laraña, Jé.; Bellas, C.; Provencio, M.; Romagosa, V.; de Sevilla, A.Fernández.; Menárguez, J.; Sabín, P.; Mestre, Mía.J.; Méndez, M.; Fresno, M.F.; Nicolás, Cón.; Piris, M.A.; García, J.F. 2006: Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma. Blood 108(2): 662-668
Kassis, J.; Klominek, J.; Kohn, E.C. 2005: Tumor microenvironment: what can effusions teach us?. Diagnostic Cytopathology 33(5): 316-319
Bacani, J.; Zwingerman, R.; Di Nicola, N.; Spencer, S.; Wegrynowski, T.; Mitchell, K.; Hay, K.; Redston, M.; Holowaty, E.; Huntsman, D.; Pollett, A.; Riddell, R.; Gallinger, S. 2005: Tumor microsatellite instability in early onset gastric cancer. Journal of Molecular Diagnostics: Jmd 7(4): 465-477
Chen, Q.; Wang, W-Chao.; Evans, S.S. 2003: Tumor microvasculature as a barrier to antitumor immunity. Cancer Immunology Immunotherapy: Cii 52(11): 670-679
Rasmussen, M.H.; Sørensen, A.B.; Morris, D.W.; Dutra, J.C.; Engelhard, E.K.; Wang, C.L.; Schmidt, J.; Pedersen, F.S. 2005: Tumor model-specific proviral insertional mutagenesis of the Fos/Jdp2/Batf locus. Virology 337(2): 353-364
Teicher, B.A. 2006: Tumor models for efficacy determination. Molecular Cancer Therapeutics 5(10): 2435-2443
Lotz, H.T.; Pos, F.J.; Hulshof, M.C.C.M.; van Herk, M.; Lebesque, J.V.; Duppen, J.C.; Remeijer, P. 2006: Tumor motion and deformation during external radiotherapy of bladder cancer. International Journal of Radiation Oncology Biology Physics 64(5): 1551-1558
Rosenzweig, K.E.; Yorke, E.; Amols, H.; Mageras, G.S.; Giraud, P.; Katz, M.S.; Leibel, S.A. 2005: Tumor motion control in the treatment of non small cell lung cancer. Cancer Investigation 23(2): 129-133
Feng, J-dong.; Xu, X-yu. 2004: Tumor multidrug-resistance and reversing actions of traditional Chinese medicine. Zhongguo Zhong Yao Za Zhi 29(9): 828-830
Xiang-Ping-Xia; Li-Yan; Zhang-Ping-An 2004: Tumor necrosis Factor-alpha gene polymorphisms and risk of coronary heart disease. Yichuan 26(6): 807-810
Langner, C.; Hutterer, G.; Chromecki, T.; Leibl, S.; Rehak, P.; Zigeuner, R. 2006: Tumor necrosis as prognostic indicator in transitional cell carcinoma of the upper urinary tract. Journal of Urology 176(3): 910
Babich, A. 2005: Tumor necrosis by controlled ebullism. Medical Hypotheses 64(2): 318-319
Edwards, J.G.; Swinson, D.E.B.; Jones, J.Louise.; Muller, S.; Waller, D.A.; O'Byrne, K.J. 2003: Tumor necrosis correlates with angiogenesis and is a predictor of poor prognosis in malignant mesothelioma. Chest 124(5): 1916-1923
Theiss, A.L.; Simmons, J.G.; Jobin, C.; Lund, P.Kay. 2005: Tumor necrosis factor (TNF) alpha increases collagen accumulation and proliferation in intestinal myofibroblasts via TNF receptor 2. Journal of Biological Chemistry 280(43): 36099-36109
Csehi, S.-B.; Mathieu, S.; Seifert, U.; Lange, A.; Zweyer, M.; Wernig, A.; Adam, D. 2005: Tumor necrosis factor (TNF) interferes with insulin signaling through the p55 TNF receptor death domain. Biochemical and Biophysical Research Communications 329(1): 397-405
Xanthoulea, S.; Pasparakis, M.; Kousteni, S.; Brakebusch, C.; Wallach, D.; Bauer, J.; Lassmann, H.; Kollias, G. 2004: Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases. Journal of Experimental Medicine 200(3): 367-376
Arai, K.Y.; Roby, K.F.; Terranova, P.F. 2005: Tumor necrosis factor alpha (TNF) suppresses cAMP response element (CRE) activity and nuclear CRE binding protein in MA-10 mouse Leydig tumor cells. Endocrine 27(1): 17-24
Lehmann, W.; Edgar, C.M.; Wang, K.; Cho, T-J.; Barnes, G.L.; Kakar, S.; Graves, D.T.; Rueger, J.M.; Gerstenfeld, L.C.; Einhorn, T.A. 2005: Tumor necrosis factor alpha (TNF-alpha) coordinately regulates the expression of specific matrix metalloproteinases (MMPS) and angiogenic factors during fracture healing. Bone 36(2): 300-310
Hou, B.; Eren, M.; Painter, C.A.; Covington, J.W.; Dixon, J.D.; Schoenhard, J.A.; Vaughan, D.E. 2004: Tumor necrosis factor alpha activates the human plasminogen activator inhibitor-1 gene through a distal nuclear factor kappaB site. Journal of Biological Chemistry 279(18): 18127-18136
Ramström, C.; Chapman, H.; Ekokoski, E.; Tuominen, R.K.; Pasternack, M.; Törnquist, K. 2004: Tumor necrosis factor alpha and ceramide depolarise the resting membrane potential of thyroid FRTL-5 cells via a protein kinase Czeta-dependent regulation of K+ channels. Cellular Signalling 16(12): 1417-1424
Trujillo, M.E.; Lee, M-Jeong.; Sullivan, S.; Feng, J.; Schneider, S.H.; Greenberg, A.S.; Fried, S.K. 2006: Tumor necrosis factor alpha and glucocorticoid synergistically increase leptin production in human adipose tissue: role for p38 mitogen-activated protein kinase. Journal of Clinical Endocrinology and Metabolism 91(4): 1484-1490
Kostadinova, R.M.; Nawrocki, A.R.; Frey, F.J.; Frey, B.M. 2005: Tumor necrosis factor alpha and phorbol 12-myristate-13-acetate down-regulate human 11beta-hydroxysteroid dehydrogenase type 2 through p50/p50 NF-kappaB homodimers and Egr-1. FASEB Journal 19(6): 650-652
McDuffie, H.H.; Nakagawa, K.; Pahwa, P.; Shindo, J.; Hashimoto, M.; Nakada, N.; Ghosh, S.; Kirychuk, S.P.; Hucl, P. 2006: Tumor necrosis factor alpha and pulmonary function in Saskatchewan grain handlers. Journal of Occupational and Environmental Medicine 48(5): 505-512
Sasaki, S.; Osanai, T.; Tomita, H.; Matsunaga, T.; Magota, K.; Okumura, K. 2004: Tumor necrosis factor alpha as an endogenous stimulator for circulating coupling factor 6. Cardiovascular Research 62(3): 578-586
Elmarakby, A.A.; Quigley, J.E.; Pollock, D.M.; Imig, J.D. 2006: Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension. Hypertension 47(3): 557-562
DiFedele, L.M.; He, J.; Bonkowski, E.L.; Han, X.; Held, M.A.; Bohan, A.; Menon, R.K.; Denson, L.A. 2005: Tumor necrosis factor alpha blockade restores growth hormone signaling in murine colitis. Gastroenterology 128(5): 1278-1291
Murphy, C.C.; Ayliffe, W.H.; Booth, A.; Makanjuola, D.; Andrews, P.A.; Jayne, D. 2004: Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis. Ophthalmology 111(2): 352-356
Turrin, N.P.; Rivest, S. 2006: Tumor necrosis factor alpha but not interleukin 1 beta mediates neuroprotection in response to acute nitric oxide excitotoxicity. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 26(1): 143-151
Poritz, L.S.; Garver, K.I.; Tilberg, A.F.; Koltun, W.A. 2004: Tumor necrosis factor alpha disrupts tight junction assembly. Journal of Surgical Research 116(1): 14-18
Kreydiyyeh, S.Ibrahim.; Markossian, S. 2006: Tumor necrosis factor alpha down-regulates the Na+-K+ ATPase and the Na+-K+2Cl- cotransporter in the kidney cortex and medulla. Cytokine 33(3): 138-144
Matikainen, S.; Sirén, J.; Tissari, J.; Veckman, V.; Pirhonen, J.; Severa, M.; Sun, Q.; Lin, R.; Meri, S.; Uzé, G.; Hiscott, J.; Julkunen, I. 2006: Tumor necrosis factor alpha enhances influenza a virus-induced expression of antiviral cytokines by activating RIG-i gene expression. Journal of Virology 80(7): 3515-3522
Moldenhauer, A.; Shieh, J.-H.; Pruss, A.; Salama, A.; Moore, M.A.S. 2004: Tumor necrosis factor alpha enhances the adenoviral transduction of CD34+ hematopoietic progenitor cells. Stem Cells 22(3): 283-291
Vitarbo, E.A.; Chatzipanteli, K.; Kinoshita, K.; Truettner, J.S.; Alonso, O.F.; Dietrich, W.Dalton. 2004: Tumor necrosis factor alpha expression and protein levels after fluid percussion injury in rats: the effect of injury severity and brain temperature. Neurosurgery 55(2): 416
Um, J.-Y.; Kim, H.-M. 2004: Tumor necrosis factor alpha gene polymorphism is associated with cerebral infarction. Brain Research. Molecular Brain Research 122(1): 99-102
Pae, C.-U.; Lee, K.-U.; Han, H.; Serretti, A.; Jun, T.-Y. 2004: Tumor necrosis factor alpha gene-G308A polymorphism associated with bipolar i disorder in the Korean population. Psychiatry Research 125(1): 65-68
Porter, K.E.; Turner, N.A.; O'Regan, D.J.; Ball, S.G. 2004: Tumor necrosis factor alpha induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin. Cardiovascular Research 64(3): 507-515
Kwon, H-Joo.; Breese, E.Haag.; Vig-Varga, E.; Luo, Y.; Lee, Y.; Goebl, M.G.; Harrington, M.A. 2004: Tumor necrosis factor alpha induction of NF-kappaB requires the novel coactivator SIMPL. Molecular and Cellular Biology 24(21): 9317-9326
Martin, J.J. 2005: Tumor necrosis factor alpha inhibitors and methotrexate: implications for deployed personnel. Aviation Space and Environmental Medicine 76(12): 1162-1166
Morceau, F.; Schnekenburger, M.; Blasius, R.; Buck, I.; Dicato, M.; Diederich, M. 2006: Tumor necrosis factor alpha inhibits aclacinomycin A-induced erythroid differentiation of K562 cells via GATA-1. Cancer Letters 240(2): 203-212
Shen, W.Hong.; Zhou, J-Hua.; Broussard, S.R.; Johnson, R.W.; Dantzer, R.; Kelley, K.W. 2004: Tumor necrosis factor alpha inhibits insulin-like growth factor I-induced hematopoietic cell survival and proliferation. Endocrinology 145(7): 3101-3105
Jayaraman, T.; Berenstein, V.; Li, X.; Mayer, J.; Silane, M.; Shin, Y.Sam.; Niimi, Y.; Kiliç, Türker.; Gunel, M.; Berenstein, A. 2005: Tumor necrosis factor alpha is a key modulator of inflammation in cerebral aneurysms. Neurosurgery 57(3): 558-64; Discussion 558-64
Haugaard, S.B.; Andersen, O.; Pedersen, S.B.; Dela, F.; Fenger, M.; Richelsen, Børn.; Madsbad, S.; Iversen, J. 2006: Tumor necrosis factor alpha is associated with insulin-mediated suppression of free fatty acids and net lipid oxidation in HIV-infected patients with lipodystrophy. Metabolism, Clinical and Experimental 55(2): 175-182
Marshall, A.C.J.; Toh, B.-H.; Alderuccio, F. 2004: Tumor necrosis factor alpha is not implicated in the genesis of experimental autoimmune gastritis. Journal of Autoimmunity 22(1): 1-11
Rostasy, K.; Gorgun, G.; Kleyner, Y.; Garcia, A.; Kramer, M.; Melanson, S.M.; Mathys, J.Marie.; Yiannoutsos, C.; Skolnik, P.R.; Navia, B.A. 2005: Tumor necrosis factor alpha leads to increased cell surface expression of CXCR4 in SK-N-MC cells. Journal of Neurovirology 11(3): 247-255
Tliba, O.; Tliba, S.; Da Huang, C.; Hoffman, R.K.; DeLong, P.; Panettieri, R.A.; Amrani, Y. 2003: Tumor necrosis factor alpha modulates airway smooth muscle function via the autocrine action of interferon beta. Journal of Biological Chemistry 278(50): 50615-50623
Séguin, C.A.; Pilliar, R.M.; Roughley, P.J.; Kandel, R.A. 2005: Tumor necrosis factor-alpha modulates matrix production and catabolism in nucleus pulposus tissue. Spine 30(17): 1940-1948
Xu, D-Xiang.; Chen, Y-Hua.; Wang, H.; Zhao, L.; Wang, J-Ping.; Wei, W. 2006: Tumor necrosis factor alpha partially contributes to lipopolysaccharide-induced intra-uterine fetal growth restriction and skeletal development retardation in mice. Toxicology Letters 163(1): 20-29
De Alvaro, C.; Teruel, T.; Hernandez, R.; Lorenzo, M. 2004: Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner. Journal of Biological Chemistry 279(17): 17070-17078
Kaden, J.J.; Kiliç, R.; Sarikoç, A.; Hagl, S.; Lang, S.; Hoffmann, U.; Brueckmann, M.; Borggrefe, M. 2005: Tumor necrosis factor alpha promotes an osteoblast-like phenotype in human aortic valve myofibroblasts: a potential regulatory mechanism of valvular calcification. International Journal of Molecular Medicine 16(5): 869-872
Tanimura, Y.; Kokuryo, T.; Tsunoda, N.; Yamazaki, Y.; Oda, K.; Nimura, Y.; Naing Mon, N.; Huang, P.; Nakanuma, Y.; Chen, M-Fu.; Jan, Y-Yin.; Yeh, T-Sen.; Chiu, C-Taug.; Hsieh, L-Ling.; Hamaguchi, M. 2005: Tumor necrosis factor alpha promotes invasiveness of cholangiocarcinoma cells via its receptor, TNFR2. Cancer Letters 219(2): 205-213
Li, M.W.M.; Xia, W.; Mruk, D.D.; Wang, C.Q.F.; Yan, H.H.N.; Siu, M.K.Y.; Lui, W-Yee.; Lee, W.M.; Cheng, C.Yan. 2006: Tumor necrosis factor {alpha} reversibly disrupts the blood-testis barrier and impairs Sertoli-germ cell adhesion in the seminiferous epithelium of adult rat testes. Journal of Endocrinology 190(2): 313-329
Richter, O.N.; Dorn, C.; Rösing, B.; Flaskamp, C.; Ulrich, U. 2005: Tumor necrosis factor alpha secretion by peritoneal macrophages in patients with endometriosis. Archives of Gynecology and Obstetrics 271(2): 143-147
Intiso, D.; Zarrelli, M.M.; Lagioia, G.; Di Rienzo, F.; Checchia De Ambrosio, C.; Simone, P.; Tonali, P.; Cioffi Dagger, R.P. 2004: Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patients. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 24(6): 390-396
Thathiah, A.; Brayman, M.; Dharmaraj, N.; Julian, J.J.; Lagow, E.L.; Carson, D.D. 2004: Tumor necrosis factor alpha stimulates MUC1 synthesis and ectodomain release in a human uterine epithelial cell line. Endocrinology 145(9): 4192-4203
Papaharalambus, C.; Sajjad, W.; Syed, A.; Zhang, C.; Bergo, M.O.; Alexander, R.Wayne.; Ahmad, M. 2005: Tumor necrosis factor alpha stimulation of Rac1 activity. Role of isoprenylcysteine carboxylmethyltransferase. Journal of Biological Chemistry 280(19): 18790-18796
Wijayagunawardane, M.Priyadarsana.Bandara.; Miyamoto, A. 2004: Tumor necrosis factor alpha system in the bovine oviduct: a possible mechanism for embryo transport. Journal of Reproduction and Development 50(1): 57-62
Tonelli, L.H.; Postolache, T.T. 2005: Tumor necrosis factor alpha, interleukin-1 beta, interleukin-6 and major histocompatibility complex molecules in the normal brain and after peripheral immune challenge. Neurological Research 27(7): 679-684
Yu, X.; Patterson, E.; Huang, S.; Garrett, M.W.; Kem, D.C. 2005: Tumor necrosis factor alpha, rapid ventricular tachyarrhythmias, and infarct size in canine models of myocardial infarction. Journal of Cardiovascular Pharmacology 45(2): 153-159
Li, X.; Zhang, R.; Luo, D.; Park, S-Joon.; Wang, Q.; Kim, Y.; Min, W. 2005: Tumor necrosis factor alpha-induced desumoylation and cytoplasmic translocation of homeodomain-interacting protein kinase 1 are critical for apoptosis signal-regulating kinase 1-JNK/p38 activation. Journal of Biological Chemistry 280(15): 15061-15070
Leibowitz, D.; Planer, D.; Ben-Ivgi, F.; Weiss, A.Teddy.; Bursztyn, M. 2005: Tumor necrosis factor and interleukin-6 levels in hypertensive patients with and without left ventricular hypertrophy. Blood Pressure 14(1): 21-24
Fenger, C.; Drojdahl, N.; Wirenfeldt, M.; Sylvest, L.; Jorgensen, O.S.; Meldgaard, M.; Lambertsen, K.L.; Finsen, B. 2006: Tumor necrosis factor and its p55 and p75 receptors are not required for axonal lesion-induced microgliosis in mouse fascia dentata. Glia 54(6): 591-605
Berthiaume, Y. 2003: Tumor necrosis factor and lung edema clearance: the tip of the iceberg?. American Journal of Respiratory and Critical Care Medicine 168(9): 1022-1023
Li, R.; Yang, L.; Lindholm, K.; Konishi, Y.; Yue, X.; Hampel, H.; Zhang, D.; Shen, Y. 2004: Tumor necrosis factor death receptor signaling cascade is required for amyloid-beta protein-induced neuron death. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 24(7): 1760-1771
Ternstrom, L.; Jeppsson, A.; Ricksten, A.; Nilsson, F. 2005: Tumor necrosis factor gene polymorphism and cardiac allograft vasculopathy. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 24(4): 433-438
Niro, G.A.; Fontana, R.; Gioffreda, D.; Valvano, M.R.; Lacobellis, A.; Facciorusso, D.; Andriulli, A. 2005: Tumor necrosis factor gene polymorphisms and clearance or progression of hepatitis B virus infection. Liver International: Official Journal of the International Association for the Study of the Liver 25(6): 1175-1181
X.S.i An; Zhu Bing; Chen Xiao Kai; Wang Zhan Ming 2003: Tumor necrosis factor in myocardial ischemia reperfusion injury in rats. Journal of China Medical University 32(6): 488-489
DiPetrillo, K.; Coutermarsh, B.; Soucy, N.; Hwa, J.; Gesek, F. 2004: Tumor necrosis factor induces sodium retention in diabetic rats through sequential effects on distal tubule cells. Kidney International 65(5): 1676-1683
Weidler, C.; Struharova, S.; Schmidt, M.; Ugele, B.; Schölmerich, Jürgen.; Straub, R.H. 2005: Tumor necrosis factor inhibits conversion of dehydroepiandrosterone sulfate (DHEAS) to DHEA in rheumatoid arthritis synovial cells: a prerequisite for local androgen deficiency. Arthritis and Rheumatism 52(6): 1721-1729
Ahmed, T.; Yumet, G.; Shumate, M.; Lang, C.H.; Rotwein, P.; Cooney, R.N. 2006: Tumor necrosis factor inhibits growth hormone-mediated gene expression in hepatocytes. American Journal of Physiology. Gastrointestinal and Liver Physiology 291(1): G35-G44
Saber, A.T.; Bornholdt, J.; Dybdahl, M.; Sharma, A.K.; Loft, S.; Vogel, U.; Wallin, Håkan. 2005: Tumor necrosis factor is not required for particle-induced genotoxicity and pulmonary inflammation. Archives of Toxicology 79(3): 177-182
Zhang, Q.; Badell, I.R.; Schwarz, E.M.; Boulukos, K.E.; Yao, Z.; Boyce, B.F.; Xing, L. 2005: Tumor necrosis factor prevents alendronate-induced osteoclast apoptosis in vivo by stimulating Bcl-xL expression through Ets-2. Arthritis and Rheumatism 52(9): 2708-2718
Chen, M.C.; Blunt, L.W.; Pins, M.R.; Klumpp, D.J. 2006: Tumor necrosis factor promotes differential trafficking of bladder mast cells in neurogenic cystitis. Journal of Urology 175(2): 754-759
Samira, S.; Ferrand, C.; Peled, A.; Nagler, A.; Tovbin, Y.; Ben-Hur, H.; Taylor, N.; Globerson, A.; Lapidot, T. 2004: Tumor necrosis factor promotes human T-cell development in nonobese diabetic/severe combined immunodeficient mice. Stem Cells 22(6): 1085-1100
George, A.; Buehl, A.; Sommer, C. 2005: Tumor necrosis factor receptor 1 and 2 proteins are differentially regulated during Wallerian degeneration of mouse sciatic nerve. Experimental Neurology 192(1): 163-166
Lotocki, G.; Alonso, O.F.; Dietrich, W.D.; Keane, R.W. 2004: Tumor necrosis factor receptor 1 and its signaling intermediates are recruited to lipid rafts in the traumatized brain. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 24(49): 11010-11016
Iosif, R.E.; Ekdahl, C.T.; Ahlenius, H.; Pronk, C.J.H.; Bonde, S.; Kokaia, Z.; Jacobsen, S.-E.W.; Lindvall, O. 2006: Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 26(38): 9703-9712
Wang, M.; Tsai, B.M.; Crisostomo, P.R.; Meldrum, D.R. 2006: Tumor necrosis factor receptor 1 signaling resistance in the female myocardium during ischemia. Circulation 114(1): I282-I289
Lind, M.H.; Rozell, B.ör.; Wallin, R.P.A.; van Hogerlinden, M.; Ljunggren, H.-G.; Toftgård, R.; Sur, I. 2004: Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-kappaB inhibition. Proceedings of the National Academy of Sciences of the United States of America 101(14): 4972-4977
Oregón-Romero, E.; Vázquez-Del Mercado, Mónica.; Navarro-Hernández, R.Elena.; Torres-Carrillo, N.; Martínez-Bonilla, G.; Estrada-García, I.; Rangel-Villalobos, Héctor.; Muñoz-Valle, Jé.Francisco. 2006: Tumor necrosis factor receptor 2 M196R polymorphism in rheumatoid arthritis and osteoarthritis: relationship with sTNFR2 levels and clinical features. Rheumatology International 27(1): 53-59
Lien, Y.-C.; Lin, S.-M.; Nithipongvanitch, R.; Oberley, T.D.; Noel, T.; Zhao, Q.; Daosukho, C.; St Clair, D.K. 2006: Tumor necrosis factor receptor deficiency exacerbated Adriamycin-induced cardiomyocytes apoptosis: an insight into the Fas connection. Molecular Cancer Therapeutics 5(2): 261-269
Waschke, K.A.; Villani, A-Chloe.; Vermeire, S.; Dufresne, L.; Chen, T-Chun.; Bitton, A.; Cohen, A.; Thomson, A.B.R.; Wild, G.E. 2005: Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes. American Journal of Gastroenterology 100(5): 1126-1133
Hostager, B.S.; Haxhinasto, S.A.; Rowland, S.L.; Bishop, G.A. 2003: Tumor necrosis factor receptor-associated factor 2 (TRAF2)-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling. Journal of Biological Chemistry 278(46): 45382-45390
Saulsbury, F.T.; Wispelwey, B. 2005: Tumor necrosis factor receptor-associated periodic syndrome in a young adult who had features of periodic fever, aphthous stomatitis, pharyngitis, and adenitis as a child. Journal of Pediatrics 146(2): 283-285
Higuchi, Y.; McTiernan, C.F.; Frye, C.B.; McGowan, B.S.; Chan, T.O.; Feldman, A.M. 2004: Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-alpha-induced cardiomyopathy. Circulation 109(15): 1892-1897
Villeneuve, Jérôme.; Tremblay, P.; Vallières, L. 2005: Tumor necrosis factor reduces brain tumor growth by enhancing macrophage recruitment and microcyst formation. Cancer Research 65(9): 3928-3936
Jansen, B.J.H.; van Ruissen, F.; Cerneus, S.; Cloin, W.; Bergers, M.; van Erp, P.E.J.; Schalkwijk, J. 2003: Tumor necrosis factor related apoptosis inducing ligand triggers apoptosis in dividing but not in differentiating human epidermal keratinocytes. Journal of Investigative Dermatology 121(6): 1433-1439
Suominen, J.S.; Wang, Y.; Kaipia, A.; Toppari, J. 2004: Tumor necrosis factor-alpha (TNF-alpha) promotes cell survival during spermatogenesis, and this effect can be blocked by infliximab, a TNF-alpha antagonist. European Journal of Endocrinology 151(5): 629-640
Amaral, M.E.; Barbuio, R.; Milanski, M.; Romanatto, T.; Barbosa, H.C.; Nadruz, W.; Bertolo, M.B.; Boschero, A.C.; Saad, M.J.A.; Franchini, K.G.; Velloso, L.A. 2006: Tumor necrosis factor-alpha activates signal transduction in hypothalamus and modulates the expression of pro-inflammatory proteins and orexigenic/anorexigenic neurotransmitters. Journal of Neurochemistry 98(1): 203-212
Kazzi, S.Nadya.J.; Jacques, S.M.; Qureshi, F.; Quasney, M.W.; Kim, U.Olivia.; Buhimschi, I.A. 2004: Tumor necrosis factor-alpha allele lymphotoxin-alpha+250 is associated with the presence and severity of placental inflammation among preterm births. Pediatric Research 56(1): 94-98
Lewis, D.E.; Merched-Sauvage, M.; Goronzy, J.ör.J.; Weyand, C.M.; Vallejo, A.N. 2004: Tumor necrosis factor-alpha and CD80 modulate CD28 expression through a similar mechanism of T-cell receptor-independent inhibition of transcription. Journal of Biological Chemistry 279(28): 29130-29138
Duvanel, Cécile.Besson.; Monnet-Tschudi, F.; Braissant, O.; Matthieu, J-Marie.; Honegger, P. 2004: Tumor necrosis factor-alpha and alphaB-crystallin up-regulation during antibody-mediated demyelination in vitro: a putative protective mechanism in oligodendrocytes. Journal of Neuroscience Research 78(5): 711-722
Vavricka, S., R.; Musch, M., W.; Fujiya, M.; Kles, K.; Chang, L.; Eloranta, J., J.; Kullak-Ublick, G., A.; Drabik, K.; Merlin, D.; Chang, E., B. 2006: Tumor necrosis factor-alpha and interferon-gamma increase PepT1 expression and activity in the human colon carcinoma cell line Caco-2/bbe and in mouse intestine. Pfluegers Archiv European Journal of Physiology 452(1): 71-80
Carrozzo, M.; Uboldi de Capei, M.; Dametto, E.; Fasano, M.Edvige.; Arduino, P.; Broccoletti, R.; Vezza, D.; Rendine, S.; Curtoni, E.Sergio.; Gandolfo, S. 2004: Tumor necrosis factor-alpha and interferon-gamma polymorphisms contribute to susceptibility to oral lichen planus. Journal of Investigative Dermatology 122(1): 87-94
Liu, Y-Peng.; Lin, H-I.; Tzeng, S-Fen. 2005: Tumor necrosis factor-alpha and interleukin-18 modulate neuronal cell fate in embryonic neural progenitor culture. Brain Research 1054(2): 152-158
Schulte-Herbrüggen, O.; Nassenstein, C.; Lommatzsch, M.; Quarcoo, D.; Renz, H.; Braun, A. 2005: Tumor necrosis factor-alpha and interleukin-6 regulate secretion of brain-derived neurotrophic factor in human monocytes. Journal of Neuroimmunology 160(1-2): 204-209
Ruscin, J.Mark.; Page, R.L.; Yeager, B.F.; Wallace, J.I. 2005: Tumor necrosis factor-alpha and involuntary weight loss in elderly, community-dwelling adults. PharmacoTherapy 25(3): 313-319
Hamaguchi, E.; Takamura, T.; Shimizu, A.; Nagai, Y. 2003: Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells. Journal of Pharmacology and Experimental Therapeutics 307(3): 987-994
Pignatelli, P.; De Biase, L.; Lenti, L.; Tocci, G.; Brunelli, A.; Cangemi, R.; Riondino, S.; Grego, S.; Volpe, M.; Violi, F. 2005: Tumor necrosis factor-alpha as trigger of platelet activation in patients with heart failure. Blood 106(6): 1992-1994
Couriel, D.; Saliba, R.; Hicks, K.; Ippoliti, C.; de Lima, M.; Hosing, C.; Khouri, I.; Andersson, B.; Gajewski, J.; Donato, M.; Anderlini, P.; Kontoyiannis, D.P.; Cohen, A.; Martin, T.; Giralt, S.; Champlin, R. 2004: Tumor necrosis factor-alpha blockade for the treatment of acute GVHD. Blood 104(3): 649-654
Raveh, D.; Shemesh, O.; Ashkenazi, Y.Jack.; Winkler, R.; Barak, V. 2004: Tumor necrosis factor-alpha blocking agent as a treatment for nephrotic syndrome. Pediatric Nephrology 19(11): 1281-1284
Peng, X-min.; Zhou, Z-gang.; Glorioso, J.C.; Fink, D.J.; Mata, M. 2006: Tumor necrosis factor-alpha contributes to below-level neuropathic pain after spinal cord injury. Annals of Neurology 59(5): 843-851
Lambert, D.W.; Yarski, M.; Warner, F.J.; Thornhill, P.; Parkin, E.T.; Smith, A.Ian.; Hooper, N.M.; Turner, A.J. 2005: Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). Journal of Biological Chemistry 280(34): 30113-30119
Medina, E.A.; Afsari, R.R.; Ravid, T.; Castillo, S.Sianna.; Erickson, K.L.; Goldkorn, T. 2005: Tumor necrosis factor-{alpha} decreases Akt protein levels in 3T3-L1 adipocytes via the caspase-dependent ubiquitination of Akt. Endocrinology 146(6): 2726-2735
Muthukumaran, N.; Miletti-González, K.E.; Ravindranath, A.K.; Rodríguez-Rodríguez, L. 2006: Tumor necrosis factor-alpha differentially modulates CD44 expression in ovarian cancer cells. Molecular Cancer Research: Mcr 4(8): 511-520
Tliba, O.; Panettieri, R.A.; Tliba, S.; Walseth, T.F.; Amrani, Y. 2004: Tumor necrosis factor-alpha differentially regulates the expression of proinflammatory genes in human airway smooth muscle cells by activation of interferon-beta-dependent CD38 pathway. Molecular Pharmacology 66(2): 322-329
Afonso, Véry.; Santos, G.; Collin, P.; Khatib, A-Majid.; Mitrovic, D.R.; Lomri, N.; Leitman, D.C.; Lomri, A. 2006: Tumor necrosis factor-alpha down-regulates human Cu/Zn superoxide dismutase 1 promoter via JNK/AP-1 signaling pathway. Free Radical Biology and Medicine 41(5): 709-721
Nagoshi, Y.; Kuwasako, K.; Cao, Y-Ning.; Imamura, T.; Kitamura, K.; Eto, T. 2004: Tumor necrosis factor-alpha downregulates adrenomedullin receptors in human coronary artery smooth muscle cells. Peptides 25(7): 1115-1121
Kawada, H.; Niwano, S.; Niwano, H.; Yumoto, Y.; Wakisaka, Y.; Yuge, M.; Kawahara, K.; Izumi, T. 2006: Tumor necrosis factor-alpha downregulates the voltage gated outward K+ current in cultured neonatal rat cardiomyocytes: a possible cause of electrical remodeling in diseased hearts. Circulation Journal: Official Journal of the Japanese Circulation Society 70(5): 605-609
Churg, A.; Wang, R.D.; Tai, H.; Wang, X.; Xie, C.; Wright, J.L. 2004: Tumor necrosis factor-alpha drives 70% of cigarette smoke-induced emphysema in the mouse. American Journal of Respiratory and Critical Care Medicine 170(5): 492-498
Vieira, B.Julião.; de Souza, A.Rodrigues.; Aarestrup, F.Monteiro. 2003: Tumor necrosis factor-alpha expression and detection of apoptosis at the site of chronic periodontitis in AIDS patients. Journal of Periodontal Research 38(6): 606-610
Loos, M.; Dihné, M.; Block, F. 2003: Tumor necrosis factor-alpha expression in areas of remote degeneration following middle cerebral artery occlusion of the rat. Neuroscience 122(2): 373-380
Bantis, C.; Heering, P.J.; Aker, S.; Siekierka, M.; Kuhr, N.; Grabensee, B.; Ivens, K. 2006: Tumor necrosis factor-alpha gene G-308A polymorphism is a risk factor for the development of membranous glomerulonephritis. American Journal of Nephrology 26(1): 12-15
Navarro, J.F.; Milena, F.J.; Mora, C.; León, C.; Claverie, F.; Flores, C.; García, J. 2005: Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition. Kidney International. Supplement 2005(99): S98-102
Zai, G.; Arnold, P.D.; Burroughs, E.; Richter, M.A.; Kennedy, J.L. 2006: Tumor necrosis factor-alpha gene is not associated with obsessive-compulsive disorder. Psychiatric Genetics 16(1): 43-45
Solari, V.; Ennis, S.; Cascio, S.; Puri, P. 2004: Tumor necrosis factor-alpha gene polymorphism in reflux nephropathy. Journal of Urology 172(4 Pt 2): 1604-6; Discussion 1606
Tan, E-Choo.; Chong, S-Ann.; Tan, C-Hoon.; Teo, Y-Ying.; Peng, K.; Mahendran, R. 2003: Tumor necrosis factor-alpha gene promoter polymorphisms in chronic schizophrenia. Biological Psychiatry 54(11): 1205-1211
Coletti, D.; Moresi, V.; Adamo, S.; Molinaro, M.; Sassoon, D. 2005: Tumor necrosis factor-alpha gene transfer induces cachexia and inhibits muscle regeneration. Genesis 43(3): 120-128
Konnai, S.; Usui, T.; Ikeda, M.; Kohara, J.; Hirata, T-ichi.; Okada, K.; Ohashi, K.; Onuma, M. 2006: Tumor necrosis factor-alpha genetic polymorphism may contribute to progression of bovine leukemia virus-infection. Microbes and Infection 8(8): 2163-2171
Maes, P.; Clement, J.; Groeneveld, P.H.P.; Colson, P.; Huizinga, T.W.J.; Van Ranst, M. 2006: Tumor necrosis factor-alpha genetic predisposing factors can influence clinical severity in nephropathia epidemica. Viral Immunology 19(3): 558-564
Ben-Mahmud, B.M.; Mann, G.E.; Datti, A.; Orlacchio, A.; Kohner, E.M.; Chibber, R. 2004: Tumor necrosis factor-alpha in diabetic plasma increases the activity of core 2 GlcNAc-T and adherence of human leukocytes to retinal endothelial cells: significance of core 2 GlcNAc-T in diabetic retinopathy. Diabetes 53(11): 2968-2976
Porcel, Jé.Manuel.; Vives, M.; Esquerda, A. 2004: Tumor necrosis factor-alpha in pleural fluid: a marker of complicated parapneumonic effusions. Chest 125(1): 160-164
Oshida, T.; Iwata, M.; Sakimoto, T.; Sawa, M. 2004: Tumor necrosis factor-alpha in tears of patients with Sjögren syndrome. Nippon Ganka Gakkai Zasshi 108(5): 297-301
Hayashi, M.; Ueda, Y.; Yamaguchi, T.; Sohma, R.; Shibazaki, M.; Ohkura, T.; Inaba, N. 2005: Tumor necrosis factor-alpha in the placenta is not elevated in pre-eclamptic patients despite its elevation in peripheral blood. American Journal of Reproductive Immunology 53(3): 113-119
Ogura, N.; Tobe, M.; Sakamaki, H.; Nagura, H.; Abiko, Y.; Kondoh, T. 2005: Tumor necrosis factor-alpha increases chemokine gene expression and production in synovial fibroblasts from human temporomandibular joint. Journal of Oral Pathology and Medicine: Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 34(6): 357-363
Yao, Z.; Li, P.; Zhang, Q.; Schwarz, E.M.; Keng, P.; Arbini, A.; Boyce, B.F.; Xing, L. 2006: Tumor necrosis factor-alpha increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through up-regulation of c-Fms expression. Journal of Biological Chemistry 281(17): 11846-11855
Hua, Y.; Wu, J.; Keep, R.F.; Nakamura, T.; Hoff, J.T.; Xi, G. 2006: Tumor necrosis factor-alpha increases in the brain after intracerebral hemorrhage and thrombin stimulation. Neurosurgery 58(3): 542
Yamauchi, N.; Harada, T.; Taniguchi, F.; Yoshida, S.; Iwabe, T.; Terakawa, N. 2004: Tumor necrosis factor-alpha induced the release of interleukin-6 from endometriotic stromal cells by the nuclear factor-kappaB and mitogen-activated protein kinase pathways. Fertility and Sterility 82(Suppl): 1023-1028
Chen, H-Cheng.; Wang, C-Jan.; Chou, C-Liang.; Lin, S-Min.; Huang, C-Da.; Lin, T-Yu.; Wang, C-Hua.; Lin, H-Chyuan.; Yu, C-Teng.; Kuo, H-Pin.; Liu, C-Ying. 2006: Tumor necrosis factor-alpha induces caspase-independent cell death in human neutrophils via reactive oxidants and associated with calpain activity. Journal of Biomedical Science 13(2): 261-273
Picchi, A.; Gao, X.; Belmadani, S.; Potter, B.J.; Focardi, M.; Chilian, W.M.; Zhang, C. 2006: Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome. Circulation Research 99(1): 69-77
Ahn, S.Y.; Cho, C.-H.; Park, K.-G.; Lee, H.J.; Lee, S.; Park, S.K.; Lee, I.-K.; Koh, G.Y. 2004: Tumor necrosis factor-alpha induces fractalkine expression preferentially in arterial endothelial cells and mithramycin a suppresses TNF-alpha-induced fractalkine expression. American Journal of Pathology 164(5): 1663-1672
Takeuchi, H.; Jin, S.; Wang, J.; Zhang, G.; Kawanokuchi, J.; Kuno, R.; Sonobe, Y.; Mizuno, T.; Suzumura, A. 2006: Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. Journal of Biological Chemistry 281(30): 21362-21368
Wang-Yan; Tao-Jun; Yang-Zhen; Tu-Chang; Xu-Ming-Guo; Wang-Jie-Mei; Huang-Yi-Jun 2005: Tumor necrosis factor-alpha induces release of endothelial microparticles from human endothelial cells. Zhonghua Xinxueguanbing Zazhi 33(12): 1137-1140
Son, D-Soo.; Roby, K.F.; Terranova, P.F. 2004: Tumor necrosis factor-alpha induces serum amyloid A3 in mouse granulosa cells. Endocrinology 145(5): 2245-2252
Plomgaard, P.; Bouzakri, K.; Krogh-Madsen, R.; Mittendorfer, B.; Zierath, J.R.; Pedersen, B.K. 2005: Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes 54(10): 2939-2945
Carter, J.D.; Valeriano, J.; Vasey, F.B. 2006: Tumor necrosis factor-alpha inhibition and VATER association: a causal relationship. Journal of Rheumatology 33(5): 1014-1017
Beyne-Rauzy, O.; Prade-Houdellier, Nïs.; Demur, Cécile.; Recher, C.; Ayel, J.; Laurent, G.; Mansat-De Mas, Véronique. 2005: Tumor necrosis factor-alpha inhibits hTERT gene expression in human myeloid normal and leukemic cells. Blood 106(9): 3200-3205
Balosso, S.; Ravizza, T.; Perego, C.; Peschon, J.; Campbell, I.L.; De Simoni, M.Grazia.; Vezzani, A. 2005: Tumor necrosis factor-alpha inhibits seizures in mice via p75 receptors. Annals of Neurology 57(6): 804-812
Hatada, K.; Washizuka, T.; Horie, M.; Watanabe, H.; Yamashita, F.; Chinushi, M.; Aizawa, Y. 2006: Tumor necrosis factor-alpha inhibits the cardiac delayed rectifier K current via the asphingomyelin pathway. Biochemical and Biophysical Research Communications 344(1): 189-193
Bauer, S.; Pollheimer, J.ür.; Hartmann, J.; Husslein, P.; Aplin, J.D.; Knöfler, M. 2004: Tumor necrosis factor-alpha inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first-trimester villous explant cultures. Journal of Clinical Endocrinology and Metabolism 89(2): 812-822
Hasegawa, S.; Nishikawa, S.; Miura, T.; Saito, Y.; Madarame, H.; Sekikawa, K.; Tagawa, Y-Ichi.; Iwakura, Y.; Nakane, A. 2004: Tumor necrosis factor-alpha is required for gastritis induced by Helicobacter felis infection in mice. Microbial Pathogenesis 37(3): 119-124
Liu, R.; Bal, H.S.; Desta, T.; Behl, Y.; Graves, D.T. 2006: Tumor necrosis factor-alpha mediates diabetes-enhanced apoptosis of matrix-producing cells and impairs diabetic healing. American Journal of Pathology 168(3): 757-764
Satoh, A.; Gukovskaya, A.S.; Edderkaoui, M.; Daghighian, M.S.; Reeve, J.R.; Shimosegawa, T.; Pandol, S.J. 2005: Tumor necrosis factor-alpha mediates pancreatitis responses in acinar cells via protein kinase C and proline-rich tyrosine kinase 2. Gastroenterology 129(2): 639-651
Lung, H-Lok.; Shan, S-Wan.; Tsang, D.; Leung, K-Nam. 2005: Tumor necrosis factor-alpha mediates the proliferation of rat C6 glioma cells via beta-adrenergic receptors. Journal of Neuroimmunology 166(1-2): 102-112
Lundblad, L.K.A.; Thompson-Figueroa, J.; Leclair, T.; Sullivan, M.J.; Poynter, M.E.; Irvin, C.G.; Bates, J.H.T. 2005: Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype. American Journal of Respiratory and Critical Care Medicine 171(12): 1363-1370
Monraats, P.S.; Pires, N.M.M.; Schepers, A.; Agema, W.R.P.; Boesten, L.S.M.; de Vries, M.R.; Zwinderman, A.H.; de Maat, M.P.M.; Doevendans, P.A.F.M.; de Winter, R.J.; Tio, Ré.A.; Waltenberger, J.; 't Hart, L.M.; Frants, R.R.; Quax, P.H.A.; van Vlijmen, B.J.M.; Havekes, L.M.; van der Laarse, A.; van der Wall, E.E.; Jukema, J.Wouter. 2005: Tumor necrosis factor-alpha plays an important role in restenosis development. FASEB Journal 19(14): 1998-2004
Guan, Y-zhou.; Cui, L-ying.; Li, Y-feng.; Zhang, J-bao. 2005: Tumor necrosis factor-alpha polymorphism and secretion in myasthenia gravis. Chinese Medical Sciences Journal 20(2): 104-107
Moffett, S.P.; Zmuda, J.M.; Oakley, J.I.; Beck, T.J.; Cauley, J.A.; Stone, K.L.; Lui, L-Yung.; Ensrud, K.E.; Hillier, T.A.; Hochberg, M.C.; Morin, P.; Peltz, G.; Greene, D.; Cummings, S.R. 2005: Tumor necrosis factor-alpha polymorphism, bone strength phenotypes, and the risk of fracture in older women. Journal of Clinical Endocrinology and Metabolism 90(6): 3491-3497
Walsmith, J.; Abad, L.; Kehayias, J.; Roubenoff, R. 2004: Tumor necrosis factor-alpha production is associated with less body cell mass in women with rheumatoid arthritis. Journal of Rheumatology 31(1): 23-29
Rodríguez-Pérez, J.é M.; Cruz-Robles, D.; Hernández-Pacheco, G.; Pérez-Hernández, N.; Murguía, L.E.; Granados, J.; Reyes, P.A.; Vargas-Alarcón, G. 2005: Tumor necrosis factor-alpha promoter polymorphism in Mexican patients with Chagas' disease. Immunology Letters 98(1): 97-102
Liu, C-Ji.; Wong, Y-Kie.; Chang, K-Wei.; Chang, H-Ching.; Liu, H-Fu.; Lee, Y-Jinn. 2005: Tumor necrosis factor-alpha promoter polymorphism is associated with susceptibility to oral squamous cell carcinoma. Journal of Oral Pathology and Medicine: Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 34(10): 608-612
Vargas-Alarcón, G.; Casasola-Vargas, J.; Rodríguez-Pérez, Jé.Manuel.; Huerta-Sil, G.; Pérez-Hernández, N.; Londoño, J.; Pacheco-Tena, C.; Cardiel, M.H.; Granados, J.; Burgos-Vargas, Rén. 2006: Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with spondyloarthritis. Human Immunology 67(10): 826-832
Boesten, L.S.M.; Zadelaar, A.Susanne.M.; van Nieuwkoop, A.; Gijbels, M.J.J.; de Winther, M.P.J.; Havekes, L.M.; van Vlijmen, B.J.M. 2005: Tumor necrosis factor-alpha promotes atherosclerotic lesion progression in APOE*3-Leiden transgenic mice. Cardiovascular Research 66(1): 179-185
Boyle, J.J.; Weissberg, P.L.; Bennett, M.R. 2003: Tumor necrosis factor-alpha promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanisms. Arteriosclerosis Thrombosis and Vascular Biology 23(9): 1553-1558
Kubota, A.; Hasegawa, K.; Suguro, T.; Koshihara, Y. 2004: Tumor necrosis factor-alpha promotes the expression of osteoprotegerin in rheumatoid synovial fibroblasts. Journal of Rheumatology 31(3): 426-435
Chen, Q.; Casali, B.; Pattacini, L.; Boiardi, L.; Salvarani, C. 2006: Tumor necrosis factor-alpha protects synovial cells from nitric oxide induced apoptosis through phosphoinositide 3-kinase Akt signal transduction. Journal of Rheumatology 33(6): 1061-1068
Wessig, J.; Brecht, S.; Claussen, M.; Roemer, L.; Goetz, M.; Bigini, P.; Schutze, S.; Herdegen, T. 2005: Tumor necrosis factor-alpha receptor 1 (p55) knockout only transiently decreases the activation of c-Jun and does not affect the survival of axotomized dopaminergic nigral neurons. European Journal of Neuroscience 22(1): 267-272
Valgimigli, M.; Ceconi, C.; Malagutti, P.; Merli, E.; Soukhomovskaia, O.; Francolini, G.; Cicchitelli, G.; Olivares, A.; Parrinello, G.; Percoco, G.; Guardigli, G.; Mele, D.; Pirani, R.; Ferrari, R. 2005: Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study. Circulation 111(7): 863-870
Leng, A.; Mura, A.; Feldon, J.; Ferger, B. 2005: Tumor necrosis factor-alpha receptor ablation in a chronic MPTP mouse model of Parkinson's disease. Neuroscience Letters 375(2): 107-111
Khabele, D.; Lopez-Jones, M.; Yang, W.; Arango, D.; Gross, S.J.; Augenlicht, L.H.; Goldberg, G.L. 2004: Tumor necrosis factor-alpha related gene response to Epothilone B in ovarian cancer. Gynecologic Oncology 93(1): 19-26
Maurin, T.; Saillan-Barreau, C.; Cousin, B.; Casteilla, L.; Doglio, A.; Pénicaud, L. 2005: Tumor necrosis factor-alpha stimulates HIV-1 production in primary culture of human adipocytes. Experimental Cell Research 304(2): 544-551
Luo, J.-Chyuan; Shin, V.-Yvonne; Yang, Y.-Hua; Wu, W.-Ka-Kei; Ye, Y.-Ni; So, W.-Hau-Leung; Chang, F.-Young; Cho, C.-Hin 2005: Tumor necrosis factor-alpha stimulates gastric epithelial cell proliferation. American Journal of Physiology Gastrointestinal and Liver Physiology 288(1): G32-G38
Leite, R.S.; Brown, A.G.; Strauss, J.F. 2004: Tumor necrosis factor-alpha suppresses the expression of steroid receptor coactivator-1 and -2: a possible mechanism contributing to changes in steroid hormone responsiveness. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 18(12): 1418-1420
Konnai, S.; Usui, T.; Ikeda, M.; Kohara, J.; Hirata, T.; Okada, K.; Ohashi, K.; Onuma, M. 2006: Tumor necrosis factor-alpha up-regulation in spontaneously proliferating cells derived from bovine leukemia virus-infected cattle. Archives of Virology 151(2): 347-360
Sarzi-Puttini, P.; Atzeni, F.; Doria, A.; Iaccarino, L.; Turiel, M. 2005: Tumor necrosis factor-alpha, biologic agents and cardiovascular risk. Lupus 14(9): 780-784
Liao, Y-Feng.; Wang, B-Jeng.; Cheng, H-Ting.; Kuo, L-Hsin.; Wolfe, M.S. 2004: Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway. Journal of Biological Chemistry 279(47): 49523-49532
Koch, W.; Tiroch, K.; von Beckerath, N.; Schömig, A.; Kastrati, A. 2003: Tumor necrosis factor-alpha, lymphotoxin-alpha, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting. Cytokine 24(4): 161-171
Hsieh, Y-Yuan.; Chang, C-Chen.; Tsai, F-Jen.; Lin, C-Chieh.; Yeh, L-Shun.; Tsai, C-Hai. 2004: Tumor necrosis factor-alpha-308 promoter and p53 codon 72 gene polymorphisms in women with leiomyomas. Fertility and Sterility 82(Suppl): 1177-1181
Bergmeier, W.; Piffath, C.L.; Cheng, G.; Dole, V.S.; Zhang, Y.; von Andrian, U.H.; Wagner, D.D. 2004: Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates GPIbalpha shedding from platelets in vitro and in vivo. Circulation Research 95(7): 677-683
Seybold, J.; Thomas, D.; Witzenrath, M.; Boral, Sül.; Hocke, A.C.; Bürger, A.; Hatzelmann, A.; Tenor, H.; Schudt, C.; Krüll, M.; Schütte, H.; Hippenstiel, S.; Suttorp, N. 2005: Tumor necrosis factor-alpha-dependent expression of phosphodiesterase 2: role in endothelial hyperpermeability. Blood 105(9): 3569-3576
Paria, B.C.; Vogel, S.M.; Ahmmed, G.U.; Alamgir, S.; Shroff, J.; Malik, A.B.; Tiruppathi, C. 2004: Tumor necrosis factor-alpha-induced TRPC1 expression amplifies store-operated Ca2+ influx and endothelial permeability. American Journal of Physiology. Lung Cellular and Molecular Physiology 287(6): L1303-L1313
Chen, J.; Li, D.; Zhang, X.; Mehta, J.L. 2004: Tumor necrosis factor-alpha-induced apoptosis of human coronary artery endothelial cells: modulation by the peroxisome proliferator-activated receptor-gamma ligand pioglitazone. Journal of Cardiovascular Pharmacology and Therapeutics 9(1): 35-41
Parkash, J.; Chaudhry, M.A.; Rhoten, W.B. 2005: Tumor necrosis factor-alpha-induced changes in insulin-producing beta-cells. Anatomical Record. Part A Discoveries in Molecular Cellular and Evolutionary Biology 286(2): 982-993
Lin, C-Chung.; Hsiao, L-Der.; Chien, C-Sung.; Lee, C-Wen.; Hsieh, J-Tsung.; Yang, C-Mao. 2004: Tumor necrosis factor-alpha-induced cyclooxygenase-2 expression in human tracheal smooth muscle cells: involvement of p42/p44 and p38 mitogen-activated protein kinases and nuclear factor-kappaB. Cellular Signalling 16(5): 597-607
Knobler, H.; Zhornicky, T.; Sandler, A.; Haran, N.; Ashur, Y.; Schattner, A. 2003: Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association. American Journal of Gastroenterology 98(12): 2751-2756
Nanami, M.; Ookawara, T.; Otaki, Y.; Ito, K.; Moriguchi, R.; Miyagawa, K.; Hasuike, Y.; Izumi, M.; Eguchi, H.; Suzuki, K.; Nakanishi, T. 2005: Tumor necrosis factor-alpha-induced iron sequestration and oxidative stress in human endothelial cells. Arteriosclerosis Thrombosis and Vascular Biology 25(12): 2495-2501
Yang, W-Lin.; Godwin, A.K.; Xu, X-Xi. 2004: Tumor necrosis factor-alpha-induced matrix proteolytic enzyme production and basement membrane remodeling by human ovarian surface epithelial cells: molecular basis linking ovulation and cancer risk. Cancer Research 64(4): 1534-1540
Candolfi, M.; Jaita, G.; Zaldivar, V.ón.; Zárate, S.; Pisera, D.; Seilicovich, A. 2004: Tumor necrosis factor-alpha-induced nitric oxide restrains the apoptotic response of anterior pituitary cells. Neuroendocrinology 80(2): 83-91
Balga, R.; Wetterwald, A.; Portenier, J.; Dolder, S.; Mueller, C.; Hofstetter, W. 2006: Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro. Bone 39(2): 325-335
Nanes, M.S. 2003: Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene 321: 1-15
Ohtori, S.; Inoue, G.; Ito, T.; Koshi, T.; Ozawa, T.; Doya, H.; Saito, T.; Moriya, H.; Takahashi, K. 2006: Tumor necrosis factor-immunoreactive cells and PGP 9.5-immunoreactive nerve fibers in vertebral endplates of patients with discogenic low back Pain and Modic Type 1 or Type 2 changes on MRi. Spine 31(9): 1026-1031
Lin, Y.; Choksi, S.; Shen, H.-M.; Yang, Q.-F.; Hur, G.M.; Kim, Y.S.; Tran, J.H.; Nedospasov, S.A.; Liu, Z.-g. 2004: Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation. Journal of Biological Chemistry 279(11): 10822-10828
Tanno, M.; Gorog, D.A.; Bellahcene, M.; Cao, X.; Quinlan, R.A.; Marber, M.S. 2003: Tumor necrosis factor-induced protection of the murine heart is independent of p38-MAPK activation. Journal of Molecular and Cellular Cardiology 35(12): 1523-1527
Polavarapu, R.; Gongora, M.Carolina.; Winkles, J.A.; Yepes, M. 2005: Tumor necrosis factor-like weak inducer of apoptosis increases the permeability of the neurovascular unit through nuclear factor-kappa B pathway activation. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 25(44): 10094-10100
Potrovita, I.; Zhang, W.; Burkly, L.; Hahm, K.; Lincecum, J.; Wang, M.Z.; Maurer, M.H.; Rossner, M.; Schneider, A.; Schwaninger, M. 2004: Tumor necrosis factor-like weak inducer of apoptosis-induced neurodegeneration. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 24(38): 8237-8244
Kishore, R.; Luedemann, C.; Bord, E.; Goukassian, D.; Losordo, D.W. 2003: Tumor necrosis factor-mediated E2F1 suppression in endothelial cells: differential requirement of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signal transduction pathways. Circulation Research 93(10): 932-940
Ruiz de Almodóvar, C.; Ruiz-Ruiz, C.; Rodríguez, A.; Ortiz-Ferrón, G.; Redondo, J.M.; López-Rivas, A. 2004: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) decoy receptor TRAIL-R3 is up-regulated by p53 in breast tumor cells through a mechanism involving an intronic p53-binding site. Journal of Biological Chemistry 279(6): 4093-4101
Morel, J.; Audo, R.; Hahne, M.; Combe, B. 2005: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt. Journal of Biological Chemistry 280(16): 15709-15718
Dai, Y.; Dent, P.; Grant, S. 2003: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) promotes mitochondrial dysfunction and apoptosis induced by 7-hydroxystaurosporine and mitogen-activated protein kinase kinase inhibitors in human leukemia cells that ectopically express Bcl-2 and Bcl-xL. Molecular Pharmacology 64(6): 1402-1409
Di Pietro, R.; Mariggiò, M.A.; Guarnieri, S.; Sancilio, S.; Giardinelli, A.; Di Silvestre, S.; Consoli, A.; Zauli, G.; Pandolfi, A. 2006: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) regulates endothelial nitric oxide synthase (eNOS) activity and its localization within the human vein endothelial cells (HUVEC) in culture. Journal of Cellular Biochemistry 97(4): 782-794
Sandra, F.; Degli Esposti, M.; Ndebele, K.; Gona, P.; Knight, D.; Rosenquist, M.; Khosravi-Far, R. 2005: Tumor necrosis factor-related apoptosis-inducing ligand alters mitochondrial membrane lipids. Cancer Research 65(18): 8286-8297
Cheung, S-shuen.C.; Metzger, D.L.; Wang, X.; Huang, J.; Tai, J.; Tingle, A.J.; Ou, D. 2005: Tumor necrosis factor-related apoptosis-inducing ligand and CD56 expression in patients with type 1 diabetes mellitus. Pancreas 30(2): 105-114
Yu-Li-Mei; Chen-Dai-Xiong; Zhou-Qi-Xin 2005: Tumor necrosis factor-related apoptosis-inducing ligand and tumor immunity. Zhongguo Yaolixue Tongbao 21(6): 657-661
Lu, X.; Arbiser, J.L.; West, J.; Hoedt-Miller, M.; Sheridan, A.; Govindarajan, B.; Harral, J.Wright.; Rodman, D.M.; Fouty, B. 2004: Tumor necrosis factor-related apoptosis-inducing ligand can induce apoptosis in subsets of premalignant cells. American Journal of Pathology 165(5): 1613-1620
Xu, J.; Zhou, J-Ying.; Wu, G.Sheng. 2006: Tumor necrosis factor-related apoptosis-inducing ligand is required for tumor necrosis factor alpha-mediated sensitization of human breast cancer cells to chemotherapy. Cancer Research 66(20): 10092-10099
Guseva, N.V.; Taghiyev, A.F.; Sturm, M.T.; Rokhlin, O.W.; Cohen, M.B. 2004: Tumor necrosis factor-related apoptosis-inducing ligand-mediated activation of mitochondria-associated nuclear factor-kappaB in prostatic carcinoma cell lines. Molecular Cancer Research: Mcr 2(10): 574-584
Baader, E.; Toloczko, A.; Fuchs, U.; Schmid, I.; Beltinger, C.; Ehrhardt, H.; Debatin, K-Michael.; Jeremias, I. 2005: Tumor necrosis factor-related apoptosis-inducing ligand-mediated proliferation of tumor cells with receptor-proximal apoptosis defects. Cancer Research 65(17): 7888-7895
Ludwig, A.T.; Moore, J.M.; Luo, Y.; Chen, X.; Saltsgaver, N.A.; O'donnell, M.A.; Griffith, T.S. 2004: Tumor necrosis factor-related apoptosis-inducing ligand: a novel mechanism for Bacillus Calmette-Guérin-induced antitumor activity. Cancer Research 64(10): 3386-3390
So, T.; Lee, S-Woo.; Croft, M. 2006: Tumor necrosis factor/tumor necrosis factor receptor family members that positively regulate immunity. International Journal of Hematology 83(1): 1-11
Temkin, V.; Pickholtz, D.; Levi-Schaffer, F. 2003: Tumor necrosis factors in a murine model of allergic peritonitis: effects on eosinophil accumulation and inflammatory mediators' release. Cytokine 24(3): 74-80
Ogoshi, F.; Yin, H.Zhen.; Kuppumbatti, Y.; Song, B.; Amindari, S.; Weiss, J.H. 2005: Tumor necrosis-factor-alpha (TNF-alpha) induces rapid insertion of Ca2+-permeable alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA)/kainate (Ca-A/K) channels in a subset of hippocampal pyramidal neurons. Experimental Neurology 193(2): 384-393
Patumraj, S.; Yoysungnoen, P.; Kachonrattanadet, P.; Wirachwong, P. 2005: Tumor neocapillary density in hepatocellular carcinoma cells implanted nude mice model. Clinical Hemorheology and Microcirculation 33(2): 137-144
Garcia, M.T.; Bejarano, P.A.; Yssa, M.; Buitrago, E.; Livingstone, A. 2006: Tumor of the liver (hepatocellular and high grade neuroendocrine carcinoma): a case report and review of the literature. Virchows Archiv: An International Journal of Pathology 449(3): 376-381
Gulley, M.L.; Swinnen, L.J.; Plaisance, K.T.; Schnell, C.; Grogan, T.M.; Schneider, B.G. 2003: Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy. Transplantation 76(6): 959-964
Menon, C.; Fraker, D.L. 2005: Tumor oxygenation status as a prognostic marker. Cancer Letters 221(2): 225-235
Gerweck, L.E.; Vijayappa, S.; Kozin, S. 2006: Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics. Molecular Cancer Therapeutics 5(5): 1275-1279
Abrial, C.; Mouret-Reynier, M.A.; Amat, S.; Sillet-Bach, I.; Bougnoux, P.; Delva, R.; Cure, H.; Dauplat, J.; Penault-Llorca, F.; Chollet, P. 2005: Tumor parameters, clinical and pathological responses, medical management, and survival through time on 710 operable breast cancers. Medical Oncology 22(3): 233-240
McKillop, D.; Partridge, E.A.; Kemp, J.V.; Spence, M.P.; Kendrew, J.; Barnett, S.; Wood, P.G.; Giles, P.B.; Patterson, A.B.; Bichat, F.; Guilbaud, N.; Stephens, T.C. 2005: Tumor penetration of gefitinib (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor. Molecular Cancer Therapeutics 4(4): 641-649
Hermans, R.; Meijerink, M.; Van den Bogaert, W.; Rijnders, A.; Weltens, C.; Lambin, P. 2003: Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. International Journal of Radiation Oncology Biology Physics 57(5): 1351-1356
Zhao, D.; Jiang, L.; Hahn, E.W.; Mason, R.P. 2005: Tumor physiologic response to combretastatin A4 phosphate assessed by MRi. International Journal of Radiation Oncology Biology Physics 62(3): 872-880
Gripp, K.W. 2005: Tumor predisposition in Costello syndrome. American Journal of Medical Genetics. Part C Seminars in Medical Genetics 137c (1): 72-77
Flores, E.R.; Sengupta, S.; Miller, J.B.; Newman, J.J.; Bronson, R.; Crowley, D.; Yang, A.; McKeon, F.; Jacks, T. 2005: Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. Cancer Cell 7(4): 363-373
Rosenberg, S.A.; Sherry, R.M.; Morton, K.E.; Scharfman, W.J.; Yang, J.C.; Topalian, S.L.; Royal, R.E.; Kammula, U.; Restifo, N.P.; Hughes, M.S.; Schwartzentruber, D.; Berman, D.M.; Schwarz, S.L.; Ngo, L.T.; Mavroukakis, S.A.; White, D.E.; Steinberg, S.M. 2005: Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma. Journal of Immunology 175(9): 6169-6176
Harlin, H.; Kuna, T.V.; Peterson, A.C.; Meng, Y.; Gajewski, T.F. 2006: Tumor progression despite massive influx of activated CD8(+) T cells in a patient with malignant melanoma ascites. Cancer Immunology Immunotherapy: Cii 55(10): 1185-1197
Lawler, J.; Detmar, M. 2004: Tumor progression: the effects of thrombospondin-1 and -2. International Journal of Biochemistry and Cell Biology 36(6): 1038-1045
Steinbrenner, H.; Ramos, M.C.; Stuhlmann, D.; Mitic, D.; Sies, H.; Brenneisen, P. 2005: Tumor promoter TPA stimulates MMP-9 secretion from human keratinocytes by activation of superoxide-producing NADPH oxidase. Free Radical Research 39(3): 245-253
Irie, K.; Masuda, A.; Shindo, M.; Nakagawa, Y.; Ohigashi, H. 2004: Tumor promoter binding of the protein kinase C C1 homology domain peptides of RasGRPs, chimaerins, and Unc13s. Bioorganic and Medicinal Chemistry 12(17): 4575-4583
Zeliadt, N.A.; Warmka, J.K.; Winston, S.E.; Kahler, R.; Westendorf, J.J.; Mauro, L.J.; Wattenberg, E.V. 2004: Tumor promoter-induced MMP-13 gene expression in a model of initiated epidermis. Biochemical and Biophysical Research Communications 317(2): 570-577
Schrenk, D.; Schmitz, H.-J.; Bohnenberger, S.; Wagner, B.; Wörner, W. 2004: Tumor promoters as inhibitors of apoptosis in rat hepatocytes. Toxicology Letters 149(1-3): 43-50
Kunz, S.; Schwarz, M.; Schilling, B.; Päpke, O.; Lehmler, H.-J.; Robertson, L.W.; Schrenk, D.; Schmitz, H.-J. 2006: Tumor promoting potency of PCBs 28 and 101 in rat liver. Toxicology Letters 164(2): 133-143
Borges, H.L.; Bird, J.; Wasson, K.; Cardiff, R.D.; Varki, N.; Eckmann, L.; Wang, J.Y.J. 2005: Tumor promotion by caspase-resistant retinoblastoma protein. Proceedings of the National Academy of Sciences of the United States of America 102(43): 15587-15592
Byrne, J.A.; Balleine, R.L.; Schoenberg Fejzo, M.; Mercieca, J.; Chiew, Y.-E.; Livnat, Y.; St Heaps, L.; Peters, G.B.; Byth, K.; Karlan, B.Y.; Slamon, D.J.; Harnett, P.; Defazio, A. 2005: Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer. International Journal of Cancer 117(6): 1049-1054
Barbado, M.; Preisser, L.; Boisdron-Celle, M.; Verriele, V.; Lorimier, G.; Gamelin, E.; Morel, A. 2006: Tumor quantification of several fluoropyrimidines resistance gene expression with a unique quantitative RT-PCR method. Implications for pretherapeutic determination of tumor resistance phenotype. Cancer Letters 242(2): 168-179
Komuro, Y.; Watanabe, T.; Tsurita, G.; Muto, T.; Nagawa, H. 2005: Tumor radiosensitivity local recurrence and disease-free survival expression pattern of telomerase reverse transcriptase in rectal carcinoma predicts. Hepato Gastroenterology 52(64): 985-989
Scotet, E.; Martinez, L.O.; Grant, E.; Barbaras, R.; Jenö, P.; Guiraud, M.; Monsarrat, B.; Saulquin, X.; Maillet, S.; Estève, J-Pierre.; Lopez, Fédéric.; Perret, B.; Collet, X.; Bonneville, M.; Champagne, E. 2005: Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I. Immunity 22(1): 71-80
Mindermann, T. 2005: Tumor recurrence and survival following gamma knife surgery for brain metastases. Journal of Neurosurgery 102(Suppl): 287-288
Schüler, T.; Körnig, S.; Blankenstein, T. 2003: Tumor rejection by modulation of tumor stromal fibroblasts. Journal of Experimental Medicine 198(10): 1487-1493
Arens, R.; Schepers, K.; Nolte, M.A.; van Oosterwijk, M.F.; van Lier, R.é A.W.; Schumacher, T.N.M.; van Oers, M.H.J. 2004: Tumor rejection induced by CD70-mediated quantitative and qualitative effects on effector CD8+ T cell formation. Journal of Experimental Medicine 199(11): 1595-1605
Lokich, J. 2004: Tumor response and survival end points in clinical trials: a clinician's perspective. American Journal of Clinical Oncology 27(5): 494-496
Howard, J.P.; Maris, J.M.; Kersun, L.S.; Huberty, J.P.; Cheng, S.-C.; Hawkins, R.A.; Matthay, K.K. 2005: Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastoma. Pediatric Blood and Cancer 44(3): 232-239
Watanabe, H.; Yamamoto, S.; Kunitoh, H.; Sekine, I.; Yamamoto, N.; Ohe, Y.; Tamura, T.; Kodama, T.; Sugimura, K.; Saijo, N. 2003: Tumor response to chemotherapy: the validity and reproducibility of RECIST guidelines in NSCLC patients. Cancer Science 94(11): 1015-1020
Rump, P.; Zeegers, M.P.A.; van Essen, A.J. 2005: Tumor risk in Beckwith-Wiedemann syndrome: a review and meta-analysis. American Journal of Medical Genetics. Part a 136(1): 95-104
Araki, A.; Hazama, S.; Yoshimura, K.; Yoshino, S.; Iizuka, N.; Oka, M. 2004: Tumor secreting high levels of IL-15 induces specific immunity to low immunogenic colon adenocarcinoma via CD8+ T cells. International Journal of Molecular Medicine 14(4): 571-576
Micali, S.; Celia, A.; Bove, P.; De Stefani, S.; Sighinolfi, M.C.; Kavoussi, L.R.; Bianchi, G. 2004: Tumor seeding in urological laparoscopy: an international survey. Journal of Urology 171(6 Pt 1): 2151-2154
Segreti, J.A.; Polakowski, J.S.; Koch, K.A.; Marsh, K.C.; Bauch, J.L.; Rosenberg, S.H.; Sham, H.L.; Cox, B.F.; Reinhart, G.A. 2004: Tumor selective antivascular effects of the novel antimitotic compound ABT-751: an in vivo rat regional hemodynamic study. Cancer ChemoTherapy and Pharmacology 54(3): 273-281
Chiosis, G.; Neckers, L. 2006: Tumor selectivity of Hsp90 inhibitors: the explanation remains elusive. Acs Chemical Biology 1(5): 279-284
Dominiecki, M.E.; Beatty, G.L.; Pan, Z-Kun.; Neeson, P.; Paterson, Y. 2005: Tumor sensitivity to IFN-gamma is required for successful antigen-specific immunotherapy of a transplantable mouse tumor model for HPV-transformed tumors. Cancer Immunology Immunotherapy: Cii 54(5): 477-488
Moss, B.L.; Taubner, L.; Sample, Y.K.; Kazmin, D.A.; Copié, V.ér.; Starkey, J.R. 2006: Tumor shedding of laminin binding protein modulates angiostatin production in vitro and interferes with plasmin-derived inhibition of angiogenesis in aortic ring cultures. International Journal of Cancer 118(10): 2421-2432
Puglisi, F.; Mansutti, M.; Aprile, G.; Minisini, A.Marco.; Di Loreto, C.; Bazzocchi, M.; Londero, V.; Cedolini, C.; Gentile, G.; Pizzolitto, S.; Piga, A.; Sobrero, A. 2004: Tumor shrinkage evaluation during and after preoperative doxorubicin and cyclophosphamide followed by docetaxel in patients with breast cancer. Anticancer Research 24(4): 2487-2493
Hashimoto, K.; Hisasue, S-ichi.; Yanase, M.; Takahashi, A.; Hisataki, T.; Kitamura, H.; Masumori, N.; Itoh, N.; Tsukamoto, T. 2005: Tumor size and regional lymph node metastasis in patients with M0 renal cell carcinoma: analysis in those having regional lymph node dissection. Hinyokika Kiyo. Acta Urologica Japonica 51(9): 621-625